$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Non-immunogenic polypeptides 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C07G-007/00
  • C07G-007/02
  • A61K-037/26
  • A61K-037/48
출원번호 US-0819831 (1977-07-28)
발명자 / 주소
  • Davis Frank F. (19 Farmingdale Rd. East Brunswick NJ 08816) Van Es Theodorus (313 Overbrook Rd. Piscataway NJ 08854) Palczuk Nicholas C. (45 W. Franklin St. Bound Brook NJ 08805)
인용정보 피인용 횟수 : 1291  인용 특허 : 3

초록

Polypeptides such as enzymes and insulin are coupled to polyethylene glycol or polypropropylene glycol having a molecular weight of 500 to 20,000 daltons to provide a physiologically active non-immunogenic water soluble polypeptide composition. The polyethylene glycol or polypropylene glycol protect

대표청구항

A physiologically active, substantially non-immunogenic water soluble polypeptide composition comprising, a physiologically active polypeptide coupled with a coupling agent to at least one substantially linear polymer having a molecular weight of between about 500 to about 20,000 daltons selected fr

이 특허에 인용된 특허 (3)

  1. Orth Hans Dieter (Darmstadt DT) Brummer Wolfgang (Darmstadt DT) Klockow Michael (Darmstadt DT) Hennrich Norbert (Darmstadt DT), Carrier matrix for the fixation of biochemically effective substances and process for the preparation thereof.
  2. Green Joseph (London EN) Cawthorne Michael Anthony (Horsham EN), Fibrinolytic compositions.
  3. Royer Garfield P. (Worthington OH), Modifying enzymes with polyethylene glycol and product produced thereby.

이 특허를 인용한 특허 (1291)

  1. Friedman, Jeffrey M.; Lee, Gwo-Hwa; Proenca, Ricardo; Ioffe, Ella, , the receptor for leptin, nucleic acids encoding the receptor, and uses thereof.
  2. Greenwald Richard B. ; Gilbert Carl W., .alpha.-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same.
  3. Donnelly, Mark; Eschenfeldt, William H.; Trent, Jonathan, 2,5-diketo-L-gluconic acid reductases and methods of use.
  4. Donnelly, Mark; Eschenfeldt, William H.; Trent, Jonathan, 2,5-diketo-L-gluconic acid reductases and methods of use.
  5. Donnelly, Mark; Eschenfeldt, William H.; Trent, Jonathan, 2,5-diketo-L-gluconic acid reductases and methods of use.
  6. Fowler, Kerry W.; Huang, Danwen; Kesicki, Edward A.; Ooi, Hua Chee; Oliver, Amy; Ruan, Fuqiang; Treiberg, Jennifer; Puri, Kamal Deep, 5-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta.
  7. Kesicki, Edward A.; Fowler, Kerry W.; Huang, Danwen; Ooi, Hua Chee; Oliver, Amy; Puri, Kamal Deep; Ruan, Fuqiang; Treiberg, Jennifer, 5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta.
  8. Fowler, Kerry W.; Huang, Danwen; Kesicki, Edward A.; Ooi, Hua Chee; Oliver, Amy; Ruan, Fuqiang; Treiberg, Jennifer; Puri, Kamal Deep, 5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta.
  9. Kesicki, Edward A.; Fowler, Kerry W.; Huang, Danwen; Ooi, Hua Chee; Oliver, Amy; Puri, Kamal Deep; Ruan, Fuqiang; Treiberg, Jennifer, 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta.
  10. Fowler, Kerry W.; Huang, Danwen; Kesicki, Edward A.; Ooi, Hua Chee; Oliver, Amy; Ruan, Fuqiang; Treiberg, Jennifer; Puri, Kamal Deep, 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta.
  11. Zalipsky Shmuel (Edison NJ), Active carbonates of polyalkylene oxides for modification of polypeptides.
  12. Sehl, Louis C.; Trollsas, Olof Mikael; Wallace, Donald G.; Toman, David; DeLustro, Frank A.; Schroeder, Jacqueline A.; Chu, George H., Adhesive tissue repair patch.
  13. Sehl, Louis C.; Trollsas, Olof Mikael; Wallace, Donald G.; Toman, David; DeLustro, Frank A.; Schroeder, Jacqueline A.; Chu, George H., Adhesive tissue repair patch and collagen sheets.
  14. Shepard, Harold Michael; Thompson, Curtis; Li, Xiaoming; Frost, Gregory I., Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects.
  15. Assaly, Ragheb; Dignam, John D.; Shapiro, Joseph I., Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction.
  16. Assaly,Ragheb; Dignam,John D.; Shapiro,Joseph I., Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction.
  17. Assaly,Ragheb; Dignam,John D.; Shapiro,Joseph I., Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction.
  18. Assaly, Ragheb A.; Dignam, J. David; Shapiro, Joseph I., Albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use.
  19. Assaly,Ragheb A.; Dignam,J. David; Shapiro,Joseph I., Albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use.
  20. Bell, Adam C.; Rosen, Craig A.; Sanyal, Indrajit; Zhao, Qinghai, Albumin-insulin fusion proteins.
  21. Ben Sasson,Shmuel A.; Cohen,Einat, Amino acid sequences capable of facilitating penetration across a biological barrier.
  22. Ekwuribe Nnochiri ; Ramaswamy Muthukumar ; Rajagopalan Jayanthi Sethuraman, Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same.
  23. Martins, Ralph; Payne, Trevor, Amyloid-β binding peptides.
  24. Wahl Robert C., Analogs of macrophage stimulating protein.
  25. Wahl Robert C., Analogs of macrophage stimulating protein.
  26. Soulillou, Jean-Paul; Laflamme, Genevieve; Vanhove, Bernard; Olive, Daniel, Anti-CD28 antibody.
  27. Berne, Pierre-Francois; Blanche, Francis; Bouchard, Hervé; Cameron, Béatrice; Dabdoubi, Tarik; Decary, Stéphanie; Ferrari, Paul; Rak, Alexey, Anti-CEACAM5 antibodies and uses thereof.
  28. Waldman, Scott A.; Magee, Michael S.; Snook, Adam E., Anti-GCC antibody molecules.
  29. Baudat, Yves; Blanche, Francis; Cameron, Béatrice; Dabdoubi, Tarik; LeFebvre, Anne-Marie; Mathieu, Magali; Merino-Trigo, Ana; Nunes, Manoel, Anti-LAMP1 antibodies and antibody drug conjugates, and uses thereof.
  30. Endl, Joseph; Eugui, Elsie M.; Fuentes, Maria Elena; Graus, Yvo; Labrijn, Aran Frank; Lanzendoerfer, Martin; Parren, Paul; Rebers, Frank; Schumacher, Ralf; Seeber, Stefan; Van De Winkel, Jan; Van Vugt, Martine, Anti-OX40L antibodies.
  31. Endl, Joseph; Eugui, Elsie M.; Fuentes, Maria Elena; Graus, Yvo; Labrijn, Aran Frank; Lanzendoerfer, Martin; Parren, Paul; Rebers, Frank; Schumacher, Ralf; Seeber, Stefan; Van De Winkel, Jan; Van Vugt, Martine, Anti-OX40L antibodies.
  32. Endl,Joseph; Eugui,Elsie M.; Fuentes,Maria Elena; Graus,Yvo; Labrijn,Aran Frank; Lanzendoerfer,Martin; Parren,Paul; Rebers,Frank; Schumacher,Ralf; Seeber,Stefan; Van De Winkel,Jan; Van Vugt,Martine, Anti-OX40L antibodies.
  33. Scholler, Nathalie; Zhao, Aizhi; Siegel, Donald; Coukos, George, Anti-TEM1 antibodies and uses thereof.
  34. Biere-Citron, Anja Leona; Jacobsen, Frederick W.; Wood, Stephen J., Anti-amyloid antibodies and uses thereof.
  35. Mytych, Daniel T.; Chirmule, Narendra; Weeraratne, Dohan K., Anti-erythropoietin antibodies.
  36. Kelley, Robert F; van Lookeren Campagne, Menno; Scheer, Justin M; Hass, Philip E; Tesar, Devin, Anti-factor D antibodies.
  37. Westerman, Mark; Ostland, Vaughn; Han, Huiling; Gutschow, Patrick; Westerman, Keith; Olbina, Gordana, Anti-hepcidin antibodies and uses thereof.
  38. Westerman, Mark; Ostland, Vaughn; Han, Huiling; Gutschow, Patrick; Westerman, Keith; Olbina, Gordana, Anti-hepcidin antibodies and uses thereof.
  39. Westerman, Mark; Ostland, Vaughn; Han, Huiling; Gutschow, Patrick; Westerman, Keith; Olbina, Gordana, Anti-hepcidin antibodies and uses thereof.
  40. Chambers, Ross S.; Brown, Michael C.; Onisk, Dale V.; Stafford, L. Joe; Yin, Fenglin, Anti-human CXCR4 antibodies and methods of making same.
  41. Fanslow, III, William Christian; Kozlosky, Carl; Gudas, Jean Marie, Anti-mesothelin binding proteins.
  42. Coukos, George; Li, Chunsheng, Anti-tumor endothelial marker-1 (TEM1) antibody variants and uses thereof.
  43. Brandt, Michael; Sankuratri, Surya; Schumacher, Ralf; Seeber, Stefan, Antibodies against CCR5 and uses thereof.
  44. Valge Archer,Viia; Williams,Andrew James; Young,Deborah A.; Whitters,Matthew J.; Collins,Mary; Witek,Joann, Antibodies against human or mouse IL-21 receptor.
  45. Xiao, Feng; Jia, Xiao-Chi; Liang, Meina; Foord, Orit; Klakamp, Scott; Tse, Kam Fai; Pollack, Vincent A.; Rastelli, Luca; Herrmann, John; Lichenstein, Henri; Jeffers, Michael; LaRochelle, William; Ara, Gulshan; Mezes, Peter; Chapoval, Andrei; Karkaria, Cyrus; Torgov, Michael; Davagnino, Juan, Antibodies directed to GPNMB and uses thereof.
  46. Johnson, Leslie S.; Huang, Ling; Moore, Paul A.; Loo, Deryk T.; Chen, Francine Z., Antibodies reactive with B7-H3 and uses thereof.
  47. Johnson, Leslie S.; Huang, Ling; Moore, Paul A.; Loo, Deryk T.; Chen, Francine Z., Antibodies reactive with B7-H3 and uses thereof.
  48. Johnson, Leslie S.; Huang, Ling; Moore, Paul A.; Loo, Deryk T.; Chen, Francine Zhifen, Antibodies reactive with B7-H3 and uses thereof.
  49. Johnson, Leslie S.; Moore, Paul A.; Huang, Ling; Loo, Deryk T.; Chen, Francine Zhifen, Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof.
  50. Johnson, Leslie S.; Moore, Paul A.; Huang, Ling; Loo, Deryk T.; Chen, Francine Zhifen, Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof.
  51. Johnson, Leslie S.; Moore, Paul A.; Huang, Ling; Loo, Deryk T.; Chen, Francine Zhifen, Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof.
  52. Pedersen, Jan Torleif; Pedersen, Lars Østergaard; Daechsel, Justus Claus Alfred; Asuni, Ayodeji Abdur-Rasheed; Rosenqvist, Nina Helen; Volbracht, Christiane; Helboe, Lone; Elvang, Anders Brandt; Sotty, Florence; Christensen, Søren; Stavenhagen, Jeffrey B., Antibodies specific for hyperphosphorylated tau and methods of use thereof.
  53. Soukupova, Monika; Schraeml, Michael; Bossenmaier, Birgit; Roche, Patrick C.; Gerg, Michael; Dziadek, Sebastian, Antibodies specifically binding to HER3.
  54. Rao, Ercole; Mikol, Vincent; Li, Danxi; Kruip, Jochen; Davison, Matthew, Antibodies that bind IL-4 and/or IL-13 and their uses.
  55. Rao, Ercole; Mikol, Vincent; Li, Danxi; Kruip, Jochen; Davison, Matthew, Antibodies that bind IL-4 and/or IL-13 and their uses.
  56. Rao, Ercole; Mikol, Vincent; Li, Danxi; Kruip, Jochen; Davison, Matthew, Antibodies that bind IL-4 and/or IL-13 and their uses.
  57. Ruben, Steven M.; Choi, Gil H.; Vaughan, Tristan; Hilbert, David, Antibodies that immunospecifically bind to B lymphocyte stimulator.
  58. Ruben, Steven M.; Barash, Steven C.; Choi, Gil H.; Vaughan, Tristan; Hilbert, David, Antibodies that immunospecifically bind to B lymphocyte stimulator protein.
  59. Ruben, Steven M.; Barash, Steven C.; Choi, Gil H.; Vaughan, Tristan; Hilbert, David, Antibodies that immunospecifically bind to B lymphocyte stimulator protein.
  60. Ruben, Steven M.; Choi, Gil H.; Vaughan, Tristan; Hilbert, David, Antibodies that immunospecifically bind to B lymphocyte stimulator protein.
  61. Salcedo,Theodora; Ruben,Steven M.; Rosen,Craig A.; Albert,Vivian R.; Dobson,Claire; Vaughan,Tristan, Antibodies that immunospecifically bind to trail receptors.
  62. Adams, Camellia W; Ashkenazi, Avi J; Chuntharapai, Anan; Kim, Kyung Jin, Antibodies to Apo-2 receptor polypeptides.
  63. Ashkenazi, Avi J.; Botstein, David; Dodge, Kelly H.; Goddard, Audrey; Gurney, Austin L.; Kim, Kyung Jin; Lawrence, David A.; Pitti, Robert; Roy, Margaret A.; Tumas, Daniel B.; Wood, William I., Antibodies to DcR3 Polypeptide, a TNFR Homolog.
  64. Yamaguchi,Kyoji; Yasuda,Hisataka; Nakagawa,Nobuaki; Shima,Nobuyuki; Kinosaki,Masahiko; Tsuda,Eisuke; Goto,Masaaki; Yano,Kazuki; Tomoyasu,Akihiro; Kobayashi,Fumie; Washida,Naohiro; Takahashi,Ken; Morinaga,Tomonori; Higashio,Kanji, Antibodies to OCIF-binding molecules.
  65. Boyle,William J.; Martin,Francis H.; Corvalan,Jose R.; Davis,C. Geoffrey, Antibodies to OPGL.
  66. Pennica, Diane; Smith, Victoria; Wood, William I., Antibodies to Stra6 polypeptides.
  67. Thomason, Arlen; Liu, Benxian, Antibodies to fibroblast growth factor-like polypeptides.
  68. Thomason, Arlen; Liu, Benxian, Antibodies to fibroblast growth factor-like polypeptides.
  69. Boyle, William J., Antibodies to osteoprotegerin binding proteins.
  70. Kim,Kyung Jin, Antibodies to vascular endothelial cell growth factor.
  71. Dahiyat, Bassil I.; Lazar, Gregory A.; Bernett, Matthew J., Antibodies with modified isoelectric points.
  72. Lazar, Gregory A.; Dahiyat, Bassil I.; Bernett, Matthew J., Antibodies with modified isoelectric points.
  73. Xiao, Shouhua; Pan, Zheng; Wickramasinghe, Dineli; Kufer, Peter; Hoffmann, Patrick; Raum, Tobias; Lutterbüse, Ralf; Nahrwold, Elisabeth; Blumel, Claudia, Antibody constructs for CDH19 and CD3.
  74. Hsei,Vanessa; Koumenis,Iphigenia; Leong,Steven; Presta,Leonard; Shahrokh,Zahra; Zapata,Gerardo, Antibody fragment-peg conjugates.
  75. Hsei, Vanessa; Koumenis, Iphigenia; Leong, Steven R.; Presta, Leonard G.; Shahrokh, Zahra; Zapata, Gerarado A., Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies.
  76. Hsei, Vanessa; Koumenis, Iphigenia; Leong, Steven; Shahrokh, Zahra; Zapata, Gerardo, Antibody fragment-polymer conjugates and uses of same.
  77. Hsei, Vanessa; Koumenis, Iphigenia; Leong, Steven; Shahrokh, Zahra; Zapata, Gerardo, Antibody fragment-polymer conjugates and uses of same.
  78. Hsei,Vanessa; Koumenis,Iphigenia; Leong,Steven; Shahrokh,Zahra; Zapata,Gerardo, Antibody fragment-polymer conjugates and uses of same.
  79. Hsei,Vanessa; Koumenis,Iphigenia; Leong,Steven; Shahrokh,Zahra; Zapata,Gerardo, Antibody fragment-polymer conjugates and uses of same.
  80. Hsei,Vanessa; Koumenis,Iphigenia; Leong,Steven; Shahrokh,Zahra; Zapata,Gerardo, Antibody fragment-polymer conjugates and uses of same.
  81. Rubin, Paul; Takeuchi, Toshihiko; Issafras, Hassan; Ahluwalia, Kiranjit; Corbin, John; Goldfine, Ira; Johnson, Kirk; Li, Ou; Bedinger, Daniel, Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemia.
  82. DeFrees, Shawn; Wang, Zhi-Guang, Antibody toxin conjugates.
  83. Greenberg, Michael L.; Matthews, Thomas James; Chen, Chin-Ho, Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrier.
  84. Baschang Gerhard (Bettingen CHX) Dietrich Felix M. (Basel CHX) Gisler Roland (Binningen CHX) Hartmann Albert (Grenzach DEX) Stanek Jaroslav (Birsfelden CHX) Tarcsay Lajos (Grenzach-Wyhlen DEX), Antigen derivatives and processes for their preparation.
  85. Stevens Vernon C., Antigenic modification of HCG polypeptides.
  86. Stevens Vernon C., Antigenic modification of polypeptides.
  87. Stevens Vernon C., Antigenic modification of polypeptides.
  88. Stevens Vernon C. (Dublin OH), Antigenic modification of polypeptides.
  89. Stevens Vernon C. (Dublin OH), Antigenic modification of polypeptides.
  90. Stevens Vernon C. (Dublin OH), Antigenic modification of polypeptides.
  91. Stevens Vernon C. (Dublin OH), Antigenic modification of polypeptides.
  92. Stevens Vernon C. (Dublin OH), Antigenic modification of polypeptides.
  93. Stevens Vernon C. (Dublin OH), Antigenic modification of polypeptides.
  94. Stevens, Vernon C., Antigenic modification of polypeptides.
  95. Scott Mark D. ; Eaton John W., Antigenic modulation of cells.
  96. Scott, Mark D.; Eaton, John W., Antigenic modulation of cells.
  97. Stevens Vernon C., Antigenically modified HCG polypeptides.
  98. Stevens Vernon C., Antigenically modified polypeptides composition.
  99. Emanuele R. Martin (Alpharetta GA) Balasubramanian Mannarsamy (Roswell GA) Allaudeen Hameedsulthan S. (Alpharetta GA), Antiinfective polyoxypropylene/polyoxyethylene copolymers and methods of use.
  100. Walsh,Scott M.; Shah,Anjali G.; Mond,James J.; Lees,Andrew; Drabick,Joseph J., Antimicrobial polymer conjugate containing lysostaphin and polyethylene glycol.
  101. Zou Hua ; Henzel William J. ; Wang Xiaodong, Apaf-1 an activator of caspase-3.
  102. Ashkenazi Avi J., Apo-2 ligand.
  103. Ashkenazi Avi J. ; Chuntharapai Anan ; Kim Kyung Jin, Apo-2 ligand.
  104. Ashkenazi, Avi J., Apo-2 ligand.
  105. Ashkenazi,Avi J., Apo-2 ligand.
  106. Ashkenazi,Avi J., Apo-2 ligand.
  107. Adams, Camellia W.; Ashkenazi, Avi J.; Chuntharapai, Anan; Kim, Kyung Jin, Apo-2 receptor agonist antibodies.
  108. Ashkenazi, Avi J., Apo-2 receptor polynucleotides.
  109. Ashkenazi, Avi J., Apo-2 receptor polypeptides.
  110. Avi J. Ashkenazi, Apo-2-receptor.
  111. Avi J. Ashkenazi, Apo-2LI and Apo-3 polypeptides.
  112. Avi J. Ashkenazi, Apo-3 polypeptide.
  113. Penninger, Josef M.; Kroemer, Guido P.; Siderovski, David Peter; Zamzami, Naoufal; Susin, Santos A.; Snow, Bryan E. L., Apoptosis-inducing factor.
  114. Penninger,Josef M.; Kroemer,Guido P.; Siderovski,David Peter; Zamzami,Naoufal; Susin,Santos A.; Snow,Bryan E. L., Apoptosis-inducing factor.
  115. Thurow Horst (Kelkheim DEX), Aqueous protein solutions stable to denaturation.
  116. Thurow Horst (Taunus DEX), Aqueous protein solutions stable to denaturation.
  117. Filpula David Ray ; Wang Maoliang, Arginine deiminase derived from Mycoplasma arthritidis and polymer conjugates containing the same.
  118. Fiipula David Ray ; Wang Maoliang, Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same.
  119. Filpula David Ray ; Wang Maoliang, Arginine deminase derived from mycoplasma arthritidis and polymer conjugates containing the same.
  120. Powell Michael J. ; Khanna Pyare ; Lingenfelter David ; Eisenbeis Scott J., Assays using cross-linked polypeptide fragments of .beta.-galactosidase.
  121. Evarts, Jerry B.; Ulrich, Roger G., Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use.
  122. Allison, Anthony, Attenuation of reperfusion injury.
  123. Grosmaire, Laura Sue; Hayden-Ledbetter, Martha Susan; Ledbetter, Jeffrey A.; Thompson, Peter Armstrong; Simon, Sandy Alexander; Brady, William, B-cell reduction using CD37-specific and CD20-specific binding molecules.
  124. Beltzer, James P.; Potter, M. Daniel; Fleming, Tony J., B-lymphocyte stimulator binding polypeptides and methods based thereon.
  125. Desjarlais, John R.; Thomason, Adam Read; Zhukovsky, Eugene Alexander, BAFF variants and methods thereof.
  126. Johnson, Leslie S.; Huang, Ling, BCR-complex-specific antibodies and methods of using same.
  127. Johnson, Leslie S.; Huang, Ling, BCR-complex-specific antibodies and methods of using same.
  128. Johnson, Leslie; Huang, Ling, BCR-complex-specific antibodies and methods of using same.
  129. Kinstler Olaf Boris ; Yan Qiao, BDNF and NT-3 polypeptides selectively linked to polyethylene glycol.
  130. Stern Robert ; Frost Gregory I. ; Hall Jackson ; Shuster Svetlana ; Formby Bent ; Colbern Gail T., BH55 hyaluronidase.
  131. Yoong, Pauline; Schuch, Raymond; Nelson, Daniel; Fischetti, Vincent A., Bacteriophage lysins for Bacillus anthracis .
  132. Yoong, Pauline; Schuch, Raymond; Nelson, Daniel; Fischetti, Vincent A., Bacteriophage lysins for and other bacteria.
  133. Colamonici, Oscar; Siddiqui, Shahid, Beta chain-associated regulator of apoptosis.
  134. Ledbetter, Jeffrey A.; Hayden-Ledbetter, Martha, Binding domain-immunoglobulin fusion proteins.
  135. Nuttal, Stewart; Streltsov, Victor; Griffiths, Katherine Merne; Carmichael, Jennifer Ann; Hudson, Peter; Irving, Robert Alexander; Varghese, Joseph Noozhumurry; Barraclough, Miles Mackay; Simmons, David Peter; Henderson, Kylie Anne, Binding moieties based on shark ignar domains.
  136. Beltzer,James P.; Potter, legal representative,Marilou; Fleming,Tony J.; Ladner,Robert Charles; Potter, deceased,M. Daniel, Binding polypeptides for B lymphocyte stimulator protein (BLyS).
  137. Smith, Richard; Bakker, Alice; Duguay, Amy N.; Li, Peng; Li, Yang, Binding proteins that bind to human FGFR1C, human β-klotho and both human FGFR1C and human β-klotho.
  138. Rhee,Woonza M.; DeLustro,Frank A.; Berg,Richard A., Biocompatible crosslinked composition.
  139. Park,Myung Ok, Biocompatible polymers including peptide spacer.
  140. Greenwald Richard B. ; Martinez Anthony J. ; Choe Yun H. ; Pendri Annapurna, Biodegradable high molecular weight polymeric linkers and their conjugates.
  141. Harris, J. Milton, Biologically active molecules having thiol moiety conjugated to polymers containing ethyl sulfone moiety.
  142. Cooper Eugene R. (Berwyn PA) Jones Stephen P. (Morpeth GBX) Pouton Colin W. (Bristol GBX) Threadgill Michael D. (Bath GBX), Biologically compatible linear block copolymers of polyalkylene oxide and peptide units.
  143. Cooper Eugene R. ; Jones Stephen P.,GBX ; Pouton Colin W.,GBX ; Threadgill Michael D.,GBX, Biologically compatible linear block copolymers of polyalkylene oxide and peptide units.
  144. Goldman, Robert D.; Shimi, Takeshi; Adam, Stephen A., Biomarker for replicative senescence.
  145. Jung, Yuni; Ho, Seong-Hyun; Park, Myung-Ok; Kim, Myoung-Suk, Biopolymer conjugates comprising an interleukin-11 analog.
  146. Doillon Charles J.,CAX ; Pietrucha Krystina,PLX ; Gaudreault Rene C.,CAX, Biostable porous material comprising composite biopolymers.
  147. Theodore Louis J. ; Kasina Sudhakar ; Reno John M. ; Gustavson Linda M., Biotinamido-n-methylglycyl-seryl-o-succinamido-benzyl dota.
  148. Powell Michael J. ; Tietze Lutz F.,DEX, Bis-maleimido cross-linking agents.
  149. Bernett, Matthew; Chu, Seung; Moore, Gregory; Desjarlais, John, Bispecific antibodies that bind to CD38 and CD3.
  150. Thomas,David; Tam,Sunny, Bispecific molecules cross-linking ITIM and ITAM for therapy.
  151. Koenig, Scott, Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof.
  152. Siekmann, Juergen; Haider, Stefan; Rottensteiner, Hanspeter; Turecek, Peter, Blood coagulation protein conjugates.
  153. DeFrees, Shawn, Branched PEG remodeling and glycosylation of glucagon-like peptide-1 [GLP-1].
  154. DeFrees, Shawn, Branched water-soluble polymers and their conjugates.
  155. DeFrees, Shawn, Branched water-soluble polymers and their conjugates.
  156. Tan, Philip; Simon, Sandy A; Cerveny, Charles G; Nilsson, Christy Anne; Brady, William; Ledbetter, Jeffrey A; Hayden-Ledbetter, Martha S; Thompson, Peter A; Morales, Cecile, CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof.
  157. Gegg, Jr., Colin V.; Johnson, Eileen J.; Miranda, Leslie P.; Walker, Kenneth W.; Holder, Jerry Ryan; Wright, Marie E.; D'Amico, Derin C., CGRP peptide antagonists and conjugates.
  158. Fujii, Nobutaka; Tamamura, Hirokazu; Hori, Akira, CXCR4 antagonist and use thereof.
  159. Ekwuribe, Nnochiri N.; Radhakrishnan, Balasingam, Calcitonin drug-oligomer conjugates, and uses thereof.
  160. Ekwuribe, Nnochiri N.; Radhakrishnan, Balasingam, Calcitonin drug-oligomer conjugates, and uses thereof.
  161. Huang, Bo; Marshall, Margaret Ann, Cancer treatment.
  162. Huang, Bo; Marshall, Margaret Ann, Cancer treatment.
  163. Kunz Horst (Mainz DEX) Braum Gunther (Wiesbaden DEX) Braun Peter (Mainz DEX), Carboxylate protective groups, a process for their preparation, their coupling to a functional group, and their use.
  164. Zhou, Mingdong, Cardiac muscle function and manipulation.
  165. Zhou,Mingdong, Cardiac muscle function and manipulation.
  166. Soliman, Tarik; Hales, Laura M.; Sard, Howard P.; Amere, Mukkanti, Carriers for improved drug delivery.
  167. Soliman, Tarik; Hales, Laura M.; Sard, Howard P.; Amere, Mukkanti, Carriers for improved drug delivery.
  168. Radhakrishnan, Balasingam; Aggarwal, Diti; Ferro, Michelle; James, Kenneth D.; Malkar, Navdeep B.; Miller, Mark A.; Puskas, Monica; Ekwuribe, Nnochiri N., Cation complexes of insulin compound conjugates, formulation and uses thereof.
  169. Radhakrishnan, Balasingam; Aggarwal, Diti; Ferro, Michelle; James, Kenneth D.; Malkar, Navdeep B.; Miller, Mark A.; Puskas, Monica; Ekwuribe, Nnochiri N., Cation complexes of insulin compound conjugates, formulations and uses thereof.
  170. Anderson, Dirk M, Cells and methods for producing blocking antibodies to human RANKL.
  171. Coutts,Stephen M.; Jones,David S.; Livingston,Douglas Alan; Yu,Lin, Chemically defined non-polymeric valency platform molecules and conjugates thereof.
  172. Inoue Masayasu (Kumamoto JPX) Maeda Hiroshi (Kumamoto JPX), Chemically modified bilirubin oxidase.
  173. Kinstler, Olaf; Gegg, Colin; Freeman, Aimee; Boone, Thomas, Chemically modified novel erythropoietin stimulating protein compositions and methods.
  174. Kinstler,Olaf; Gegg,Colin; Freeman,Aimee; Boone,Thomas, Chemically modified novel erythropoietin stimulating protein compositions and methods.
  175. Kinstler,Olaf; Gegg,Colin; Freeman,Aimee; Boone,Thomas, Chemically modified novel erythropoietin stimulating protein compositions and methods.
  176. Nakagawa Yasushi (Kawanishi JPX) Ito Takashi (Osaka JPX), Chemically modified protein with polyethyleneglycol.
  177. Coutts,Stephen M.; Jones,David S.; Livingston,Douglas Alan; Yu,Lin, Chemically-defined non-polymeric valency platform molecules and conjugates thereof.
  178. Ishikawa Rika,JPX ; Okada Yuji,JPX ; Kakitani Makoto,JPX, Chemically-modified G-CSF.
  179. Ishikawa Rika,JPX ; Okada Yuji,JPX ; Kakitani Makoto,JPX, Chemically-modified G-CSF.
  180. Crowe, Brian A.; Livey, Ian; O'Rourke, Maria; Schwendinger, Michael, Chimeric OspA genes, proteins and methods of use thereof.
  181. Crowe, Brian A.; Livey, Ian; O'Rourke, Maria; Schwendinger, Michael; Dunn, John J.; Luft, Benjamin J., Chimeric OspA genes, proteins and methods of use thereof.
  182. Crowe, Brian A.; Livey, Ian; O'Rourke, Maria; Schwendinger, Michael, Chimeric OspA genes, proteins, and methods of use thereof.
  183. Crowe, Brian A.; Livey, Ian; O'Rourke, Maria; Schwendinger, Michael; Dunn, John J.; Luft, Benjamin J., Chimeric OspA genes, proteins, and methods of use thereof.
  184. Crowe, Brian A.; Livey, Ian; O'Rourke, Maria; Schwendinger, Michael; Dunn, John J.; Luft, Benjamin J., Chimeric OspA proteins and methods of use thereof.
  185. Sonoda, Junichiro, Chimeric fibroblast growth factors with altered receptor specificity.
  186. Erickson, Mary, Chimeric leptin polypeptide and method of using the same.
  187. Li, Yang; Wu, Xinle; Wang, Zhulun, Chimeric polypeptides and uses thereof.
  188. Nakayama, Naoki; Wen, Duanzhi; Han, Chun-ya; He, Ching; Yu, Dongyin, Chordin-like molecules and uses thereof.
  189. Nakayama,Naoki; Wen,Duanzhi; Han,Chun ya; He,Ching; Yu,Dongyin, Chordin-like molecules and uses thereof.
  190. Nakayama,Naoki; Wen,Duanzhi; Han,Chun ya; He,Ching; Yu,Dongyin, Chordin-like molecules and uses thereof.
  191. Theodore Louis J. ; Axworthy Donald B., Cluster clearing agents.
  192. Theodore, Louis J.; Axworthy, Donald B., Cluster clearing agents.
  193. Schellenberger, Volker; Stemmer, Willem P.; Geething, Nathan C.; To, Wayne; Silverman, Joshua; Wang, Chia-wei; Spink, Benjamin, Coagulation factor IX compositions and methods of making and using same.
  194. Schellenberger, Volker; Stemmer, Willem P.; Geething, Nathan C.; To, Wayne; Silverman, Joshua; Wang, Chia-wei; Spink, Benjamin, Coagulation factor IX compositions and methods of making and using same.
  195. Persson,Egon, Coagulation factor VII derivatives.
  196. Caldwell Karin Maria Elisabet ; Carlsson Per Jan Erik,SEX ; Li Jenq-Thun, Coating of hydrophobic surfaces to render them protein resistant while permitting covalent attachment of specific ligan.
  197. Rhee Woonza M. ; Berg Richard A., Collagen-synthetic polymer matrices prepared using a multiple step reaction.
  198. Tuaillon, Nadine; Rankin, Christopher, Combination of FcγRIIB-specific antibodies and CD20-specific antibodies and methods of use thereof.
  199. Tuaillon, Nadine; Rankin, Christopher, Combination of FcγRIIB-specific antibodies and CD20-specific antibodies and methods of use thereof.
  200. Bendele Alison M. ; Sennello Regina M. ; Edwards III Carl K., Combination therapy using a TNF binding protein for treating TNF-mediated diseases.
  201. Maneval, Daniel C.; Shepard, H. Michael; Thompson, Curtis B., Combination therapy with an anti-hyaluronan agent and therapeutic agent.
  202. Maneval, Daniel C.; Shepard, H. Michael; Thompson, Curtis B., Combination therapy with an anti-hyaluronan agent and therapeutic agent.
  203. Jiang, Ping; Shepard, H. Michael; Huang, Lei, Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof.
  204. Jiang, Ping; Shepard, H. Michael; Huang, Lei, Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof.
  205. Baciu, Peter C.; Liang, Yanbin; Guu, Jason; Bernett, Matthew; Muchhal, Umesh; Desjarlais, John, Complement component C5 antibodies.
  206. Li, Xiaoming; Ramprasad, Mysore; Thompson, Curtis; Shepard, Harold Michael; Bookbinder, Louis Howard; Frost, Gregory Ian, Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia.
  207. Caldwell Karin D. ; Tresco Patrick A. ; Neff Jennifer, Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces.
  208. Caldwell, Karin D.; Tresco, Patrick A.; Neff, Jennifer, Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces.
  209. Caldwell,Karin D.; Tresco,Patrick A.; Neff,Jennifer, Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces.
  210. Rhee, Woonza M.; DeLustro, Frank A.; Berg, Richard A., Composition for administration of a biologically active compound.
  211. Sabbadini, Roger A.; Garland, William A.; Hansen, Genevieve; Swaney, James Stephen, Compositions and methods for binding lysophosphatidic acid.
  212. Sabbadini, Roger A.; Garland, William A.; Hansen, Genevieve; Swaney, James Stephen; Matteo, Rosalia; Mills, Gordon; Wojciak, Jonathan Michael, Compositions and methods for binding lysophosphatidic acid.
  213. Morris, David W.; Engelhard, Eric K., Compositions and methods for cancer.
  214. Morris, David W.; Engelhard, Eric K., Compositions and methods for cancer.
  215. Schurpf, Thomas; Mahanthappa, Nagesh K.; Straub, Michelle Marie, Compositions and methods for growth factor modulation.
  216. Schurpf, Thomas; Mahanthappa, Nagesh K.; Straub, Michelle Marie, Compositions and methods for growth factor modulation.
  217. Schurpf, Thomas; Mahanthappa, Nagesh K.; Straub, Michelle Marie, Compositions and methods for growth factor modulation.
  218. Lazar, Gregory A.; Moore, Gregory L., Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens.
  219. DeFrees, Shawn, Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants.
  220. Simonet, Scott; Sarosi, Ildiko, Compositions and methods for the prevention and treatment of cardiovascular diseases.
  221. Sabbadini, Roger A.; Cavalli, Amy L.; Garland, William A., Compositions and methods for the treatment and prevention of hyperproliferative diseases.
  222. Chuang, Woei-Jer; Fu, Wen-Mei; Huang, Yen-Lun, Compositions and methods for the treatment of angiogenesis-related eye diseases.
  223. Morris, David W.; Engelhard, Eric K., Compositions and methods in cancer associated with altered expression of KCNJ9.
  224. Morris, David W.; Engelhard, Eric K., Compositions and methods in cancer associated with altered expression of PRLR.
  225. Daniloff, George Y.; Sehl, Louis C.; Trollsas, Olof Mikael; Schroeder, Jacqueline A.; Gravett, David M.; Toleikis, Philip M., Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use.
  226. Daniloff, George Y.; Sehl, Louis C.; Trollsas, Olof Mikael; Schroeder, Jacqueline A.; Gravett, David M.; Toleikis, Philip M., Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use.
  227. Daniloff, George Y.; Sehl, Louis C.; Trollsas, Olof Mikael; Schroeder, Jacqueline; Gravett, David M.; Toleikis, Philip M., Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use.
  228. Olof Mikael Trollsas ; Donald G. Wallace ; Frank A. DeLustro, Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use.
  229. Sehl, Louis C.; Trollsas, Olof Mikael; Wallace, Donald G.; Toman, David; DeLustro, Frank A.; Schroeder, Jacqueline A.; Chu, George H., Compositions and systems for forming crosslinked biomaterials and methods of preparation of use.
  230. Harris, J. Milton; Kozlowski, Antoni; McManus, Samuel P.; Bentley, Michael D.; Charles, Stephen A., Compositions comprising a polymeric reagent and a pharmacologically active agent.
  231. Barrett, P. Noel; Aichinger, Gerald; Crowe, Brian A.; Livey, Ian; Wressnigg, Nina, Compositions comprising chimeric OSPA molecules and methods of use thereof.
  232. Bossard, Mary J., Compositions comprising two different populations of polymer-active agent conjugates.
  233. Zhao, Allan Z., Compositions for blocking the inhibitory effect of human CRP on human leptin.
  234. Yaspan, Brian; Graham, Robert Royal; Dressen, Amy; Li, Zhengrong; Strauss, Erich; Bugawan, Teodorica, Compositions for detecting complement factor H (CFH) and complement factor I (CFI) polymorphisms.
  235. Winslow, Robert M.; Vandegriff, Kim D., Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin.
  236. Winslow, Robert M.; Vandegriff, Kim D., Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin.
  237. Kriegler Michael ; Perez Carl ; Halenbeck Robert F. ; Jewell David A. ; Koths Kirston E., Compositions for the inhibition of TNF hormone formation and uses thereof.
  238. Thanos, Christopher D.; Wang, Lin; Shepard, H. Michael, Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same.
  239. Patton, John S.; Kuo, Mei-Chang; Harris, J. Milton; Leach, Chester; Perkins, Kimberly; Bueche, Blaine, Compositions of chemically modified insulin.
  240. Mosberg, Henry I., Compound and method for modulating opioid receptor activity.
  241. Kudirka, Romas Alvydas; Albers, Aaron Edward; Rabuka, David, Compounds and methods for producing a conjugate.
  242. Bloom, Stephen Robert, Compounds and their effects on feeding behaviour.
  243. Bloom, Stephen Robert, Compounds and their effects on feeding behaviour.
  244. Bloom, Stephen Robert, Compounds and their effects on feeding behaviour.
  245. Duocastella Codina, Lluis; Molina, Maria; Arad, Ofir; Borrell Bilbao, Jose Ignacio; Garcia, David Sanchez; Petterson Salom, Sofia Henriette, Compounds for the synthesis of biostable polyurethane, polyurea or polyurea urethane polymers.
  246. Block, Lutz-Henning, Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension.
  247. Zalipsky,Samuel; Gabizon,Alberto A., Conjugate having a cleavable linkage for use in a liposome.
  248. Zalipsky,Samuel; Gabizon,Alberto A., Conjugate having a cleavable linkage for use in a liposome.
  249. Camble Roger,GB2 ; Timms David,GB2 ; Wilkinson Anthony James,GB2, Conjugate of a solution stable G-CSF derivative and a water-soluble polymer.
  250. Bolt, Gert; Vandahl, Brian Berg Stidsen; Thim, Lars; Stennicke, Henning Ralf; Steenstrup, Thomas Dock; DeFrees, Shawn, Conjugated factor VIII molecules.
  251. Gengrinovitch, Stela; Izakovich, Esther, Conjugates for cancer therapy and diagnosis.
  252. Gengrinovitch, Stela; Izakovich, Esther, Conjugates for cancer therapy and diagnosis.
  253. Bos, Ebo Sijbren; De Kort, Martin; Smit, Meertinus Jan; Van Boeckel, Constant Adriaan Anton, Conjugates of a polypeptide and a pentasaccharide.
  254. Eichner, Wolfram; Schimmel, Martin; Hacket, Frank; Kraus, Elmar; Zander, Norbert; Frank, Ronald; Conradt, Harald; Langer, Klaus; Orlando, Michele; Sommermeyer, Klaus, Conjugates of hydroxyalkyl starch and a protein.
  255. Eichner, Wolfram; Schimmel, Martin; Hacket, Frank; Kraus, Elmar; Zander, Norbert; Frank, Ronald; Conradt, Harald; Langer, Klaus; Orlando, Michele; Sommermeyer, Klaus, Conjugates of hydroxyalkyl starch and a protein.
  256. Eichner, Wolfram; Orlando, Michele; Zander, Norbert; Conradt, Harald S.; Hacket, Frank; Langer, Klaus; Frank, Ronald, Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination.
  257. Sommermeyer, Klaus; Eichner, Wolfram; Frie, Sven; Jungheinrich, Cornelius; Scharpf, Roland; Lutterbeck, Katharina; Hemberger, Jurgen; Orlando, Michele, Conjugates of hydroxyalkyl starch and an active agent.
  258. Garman Andrew J. (Betchworth GBX), Conjugates of pharmaceutically useful proteins.
  259. Saifer Mark (Berkeley CA) Somack Ralph (Oakland CA) Williams L. David (Fremont CA), Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols.
  260. Shadle Paula J. (Richmond CA) Koths Kirston E. (El Cerrito CA) Moreland Margaret (Berkeley CA) Katre Nandini (El Cerrito CA), Conjugation of polymer to colony stimulating factor-1.
  261. Bisgard-Frantzen Henrik,DKX ; Olsen Arne Agerlin,DKX ; Prento Annette,DKX, Conjugation of polypeptides.
  262. Camble, Roger; Timms, David; Wilkinson, Anthony J., Continuous release pharmaceutical compositions.
  263. Southard, Jeffrey L.; Southard, George L., Controlled release CGRP delivery composition for cardiovascular and renal indications.
  264. Orlando, Michele; Hemberger, Jurgen; Sommermeyer, Klaus; Eichner, Wolfram; Frie, Sven; Lutterbeck, Katharina; Jungheinrich, Cornelius; Scharpf, Roland, Coupling low-molecular substances to a modified polysaccharide.
  265. Hemberger, Jurgen; Orlando, Michele; Sommermeyer, Klaus; Eichner, Wolfram; Frie, Sven; Lutterbeck, Katharina; Jungheinrich, Cornelius; Scharpf, Roland, Coupling proteins to a modified polysaccharide.
  266. Hemberger, Jurgen; Orlando, Michele; Sommermeyer, Klaus; Eichner, Wolfram; Frie, Sven; Lutterbeck, Katharina; Jungheinrich, Cornelius; Scharpf, Roland, Coupling proteins to a modified polysaccharide.
  267. Rhee, Woonza M.; DeLustro, Frank A.; Berg, Richard A., Cross-linked polymer compositions and methods for their use.
  268. Powell Michael J. ; Khanna Pyare ; Eisenbeis Scott J. ; Lingenfelter David ; Tietze Lutz F.,DEX, Cross-linked polypeptide fragments of .beta.-galactosidase.
  269. Rhee,Woonza M.; DeLustro,Frank A.; Berg,Richard A., Crosslinked polymer compositions.
  270. Rhee Woonza M. ; DeLustro Frank A. ; Berg Richard A., Crosslinked polymer compositions and methods for their use.
  271. Rhee Woonza M. ; DeLustro Frank A. ; Berg Richard A., Crosslinked polymer compositions and methods for their use.
  272. Ohri, Rachit; Blaskovich, Phillip; Kennedy, Joshua; Bennett, Steven L.; Driscoll, Arthur, Crosslinked polymers with the crosslinker as therapeutic for sustained release.
  273. Ohri, Rachit; Blaskovich, Phillip; Kennedy, Joshua; Bennett, Steven L.; Driscoll, Arthur, Crosslinked polymers with the crosslinker as therapeutic for sustained release.
  274. Clogston, Christi L., Crystalline polypeptides.
  275. Goddard, Audrey; Godowski, Paul J.; Gurney, Austin L.; Watanabe, Colin K.; Wood, William I., Cytokine receptor and nucleic acids encoding the same.
  276. Goddard,Audrey; Godowski,Paul J.; Gurney,Austin L.; Watanabe,Colin K.; Wood,William I., Cytokine receptors and nucleic acids encoding the same.
  277. Gregory, Philip D.; Miller, Jeffrey C.; Paschon, David; Rebar, Edward J.; Tan, Siyuan; Urnov, Fyodor; Zhang, Lei, DNA-binding proteins and uses thereof.
  278. Gregory, Philip D.; Miller, Jeffrey C.; Paschon, David; Rebar, Edward J.; Tan, Siyuan; Urnov, Fyodor; Zhang, Lei, DNA-binding proteins and uses thereof.
  279. Gregory, Philip D.; Miller, Jeffrey C.; Paschon, David; Rebar, Edward J.; Tan, Siyuan; Urnov, Fyodor; Zhang, Lei, DNA-binding proteins and uses thereof.
  280. Gregory, Philip D.; Miller, Jeffrey C.; Paschon, David; Rebar, Edward J.; Tan, Siyuan; Urnov, Fyodor; Zhang, Lei, DNA-binding proteins and uses thereof.
  281. Gregory, Philip D.; Miller, Jeffrey C.; Paschon, David; Rebar, Edward J.; Tan, Siyuan; Urnov, Fyodor; Zhang, Lei, DNA-binding proteins and uses thereof.
  282. Gregory, Philip D.; Miller, Jeffrey C.; Paschon, David; Rebar, Edward J.; Tan, Siyuan; Urnov, Fyodor; Zhang, Lei, DNA-binding proteins and uses thereof.
  283. Friedman, Jeffrey M.; Lee, Gwo Hwa; Proenca, Ricardo, Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof.
  284. Ni, Jian; Rosen, Craig A.; Pan, James G.; Gentz, Reiner L.; Dixit, Vishva M., Death domain containing receptor 4.
  285. Ni, Jian; Rosen, Craig A.; Pan, James G.; Gentz, Reiner L.; Dixit, Vishva M., Death domain containing receptor 4 antibodies and methods.
  286. Ni,Jian; Rosen,Craig A.; Pan,James G.; Gentz,Reiner L.; Dixit,Vishva M., Death domain containing receptor 4 antibodies and methods.
  287. Ni,Jian; Rosen,Craig A.; Pan,James; Gentz,Reiner L.; Dixit,Vishva M., Death domain containing receptor 4 antibody and methods.
  288. Jian Ni ; Craig A. Rosen ; James G. Pan ; Reiner L. Gentz ; Vishva M. Dixit, Death domain containing receptor-4.
  289. Yu, Guo-Liang; Ni, Jian; Dixit, Vishva M.; Gentz, Reiner L.; Dillon, Patrick J., Death domain containing receptors.
  290. Yu, Guo-Liang; Ni, Jian; Dixit, Vishva; Gentz, Reiner L.; Dillon, Patrick J., Death domain containing receptors.
  291. Yu, Guo-Liang; Ni, Jian; Gentz, Reiner L.; Dillon, Patrick J., Death domain containing receptors.
  292. Harris,J. Milton; Zhao,Xuan, Degradable heterobifunctional poly(ethylene glycol) acrylates.
  293. Harris,J. Milton; Zhao,Xuan, Degradable heterobifunctional poly(ethylene glycol) acrylates.
  294. J. Milton Harris ; Xuan Zhao, Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom.
  295. Kuwano,Mitsuaki; Nakagawa,Masaki; Suhara,Hiroshi, Delivering substance and drug delivery system using the same.
  296. Viswanathan Ravi (Terre Haute IN) DePrince Randolph B. (Terre Haute IN), Delivery device for the administration of stabilized growth promoting hormones.
  297. Mirkin, Chad A.; Paller, Amy S.; Giljohann, David A., Delivery of oligonucleotide functionalized nanoparticles.
  298. Harris, J. Milton, Delivery of poly (ethylene glycol)-modified molecules from degradable hydrogels.
  299. Harris J. Milton, Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels.
  300. Harris,J. Milton, Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels.
  301. J. Milton Harris, Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels.
  302. Magruder, Judy A.; Eckenhoff, James B.; Cortese, Richard; Wright, Jeremy C.; Peery, John R., Delivery system comprising first walled section and second walled section united by fusion, adhesion or telescopic engagement.
  303. Magruder Judy A. (Mt. View CA) Eckenhoff James B. (Los Altos CA) Cortese Richard (Los Gatos CA) Wright Jeremy C. (Los Altos CA) Peery John R. (Palo Alto CA), Delivery system comprising means for governing fluid into the system and for restricting fluid into the system.
  304. Magruder, Judy A.; Eckenhoff, James B.; Cortese, Richard; Wright, Jeremy C.; Peery, John R., Delivery system comprising two sections for delivering somatotropin.
  305. Lanzavecchia, Antonio, Dengue virus neutralizing antibodies and use thereof.
  306. Madsen, Peter; Tagmose, Tina Moeller; Naver, Helle; Kjeldsen, Thomas Boerglum, Derivative of an insulin analogue.
  307. Ho, Guan Huei; Yang, Tou Hsiung; Yang, Jeng, Dietary products comprising one or more of γ-polyglutamic acid (γ-PGA, H form) and γ-polyglutamates for use as nutrition supplements.
  308. Magruder Judy A. (Mt. View CA) Eckenhoff James B. (Los Altos CA) Cortese Richard (Los Gatos CA) Wright Jeremy C. (Los Altos CA) Peery John R. (Palo Alto CA), Dispenser for increasing feed conversion of hog.
  309. Zhou, Weidong; Liao, Xiaojin; Sun, Li; Zhang, Linzhong; Lu, Qingsong; Shen, Shiye; Yang, Lishan; Zhang, Defang; Lin, Huihuang; Zhang, Ping, Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof.
  310. Gravett, David M.; Takacs-Cox, Aniko; Toleikis, Philip M.; Maiti, Arpita; Embree, Leanne, Drug delivery from rapid gelling polymer composition.
  311. Ekwuribe,Nnochiri N.; Ramaswamy,Muthukumar; Rajagopalan,Jayanthi, Drug-oligomer conjugates with polyethylene glycol components.
  312. Rasmussen, Grethe Nørskov; Kindermann, Susanne; Rau, Harald; Wegge, Thomas, Dry growth hormone composition transiently linked to a polymer carrier.
  313. Rasmussen, Grethe Nørskov; Kindermann, Susanne; Rau, Harald; Wegge, Thomas, Dry growth hormone composition transiently linked to a polymer carrier.
  314. Hsu, Jeff; Masat, Linda; Abraham, Judy; Handa, Masahisa; Schleyer, Siew, EPHB3-specific antibody and uses thereof.
  315. Hsu, Jeff; Masat, Linda; Abraham, Judy; Handa, Masahisa; Schleyer, Siew, EPHB3-specific antibody and uses thereof.
  316. Erickson, Mary; Litzinger, David C.; Ghosh, Soumitra S.; Guo, Zijian; Ekblad, Caroline; Roth, Jonathan D., Engineered polypeptides having enhanced duration of action and reduced immunogenicity.
  317. Stavenhagen, Jeffrey; Koenig, Scott, Engineering Fc antibody regions to confer effector function.
  318. Zalipsky Samuel ; Woodle Martin C. ; Martin Francis J. ; Barenholz Yechezkel,ILX, Enhanced circulation effector composition and method.
  319. Zalipsky, Samuel; Woodle, Martin C.; Martin, Francis J.; Barenholz, Yechezkel; Bercovier, Herve, Enhanced circulation effector composition and method.
  320. Zalipsky,Samuel; Woodle,Martin C.; Martin,Francis J.; Barenholz,Yechezkel; Bercovier,Herve, Enhanced circulation effector composition and method.
  321. Zalipsky,Samuel; Woodle,Martin C.; Martin,Francis J.; Barenholz,Yechezkel; Bercovier,Herve, Enhanced circulation effector composition and method.
  322. Zalipsky Samuel ; Woodle Martin C. ; Martin Francis J. ; Barenholz Yechezkel,ILX, Enhanced ciruclation effector composition and method.
  323. Nho Kwang (Somerset NJ), Enhancement of antitumor therapy with hemoglobin-based conjugates.
  324. Ekwuribe, Nnochiri N.; Rhadakrishnan, Balasingam; Price, Christopher H.; Anderson Jr., Wes; Ansari, Aslam M., Enkephalin conjugates.
  325. Harrison, Jr., Roger G.; Krais, John J., Enzyme conjugate and prodrug cancer therapy.
  326. Kokai Kun, John F.; Adams, Julie M.; Mond, James J.; Walsh, Scott M.; Shah, Anjali G.; Chanturiya, Tanya I., Enzyme disruption of bacterial biofilms.
  327. McIver John McMillan ; Underiner Todd Laurence ; Bates Timothy, Enzyme inhibitors.
  328. Asgharian Bahram ; Hong Bor-Shyue ; Quintana Ronald P., Enzymes with low isoelectric points for use in contact lens cleaning.
  329. Bailon, Pascal Sebastian, Erythropoietin conjugates.
  330. Duliege, Anne Marie; Stead, Richard; Leuther, Kerstin; Woodburn, Kathryn; Naso, Robert Barnett, Erythropoietin receptor peptide formulations and uses.
  331. Duliege, Anne-Marie; Stead, Richard; Leuther, Kerstin; Woodburn, Kathryn Wynne; Naso, Robert Barnett, Erythropoietin receptor peptide formulations and uses.
  332. DeFrees, Shawn; Zopf, David A.; Bayer, Robert J.; Bowe, Caryn; Hakes, David James; Chen, Xi, Erythropoietin: remodeling and glycoconjugation of erythropoietin.
  333. DeFrees, Shawn; Zopf, David A.; Bayer, Robert J.; Hakes, David James; Bowe, Caryn; Chen, Xi, Erythropoietin: remodeling and glycoconjugation of erythropoietin.
  334. DeFrees,Shawn; Zopf,David A.; Bayer,Robert J.; Bowe,Caryn; Hakes,David James; Chen,Xi, Erythropoietin: remodeling and glycoconjugation of erythropoietin.
  335. Kolterman,Orville G.; Young,Andrew A.; L'Italien,James J., Exendin analog formulations.
  336. Prickett, Kathryn S.; Young, Andrew A., Exendins and exendin agonists modified with albumin.
  337. Prickett, Kathryn S.; Young, Andrew A., Exendins and exendin agonists modified with polyamino acids.
  338. Wei, Ge; Selvam, Krishnasamy Panneer; Bookbinder, Louis; Frost, Gregory I., Extended soluble PH20 polypeptides and uses thereof.
  339. Belouski, Edward John; Ellison, Murielle Marie; Hamburger, Agnes Eva; Hecht, Randy Ira; Li, Yue-Sheng; Michaels, Mark Leo; Sun, Jeonghoon; Xu, Jing, FGF 21 polypeptides comprising two or more mutations and uses thereof.
  340. Belouski, Edward John; Ellison, Murielle Marie; Hamburger, Agnes Eva; Hecht, Randy Ira; Li, Yue-Sheng; Michaels, Mark Leo; Sun, Jeonghoon; Xu, Jing, FGF mutants with reduced proteolysis and aggregation.
  341. Walker, Kenneth W.; Gegg, Jr., Colin V.; Hecht, Randy I.; Belouski, Edward J.; Li, Yue-Sheng; Michaels, Mark L.; Xu, Jing; Ellison, Murielle M., FGF-21 mutants comprising polyethylene glycol and uses thereof.
  342. Belouski, Edward John; Ellison, Murielle Marie; Hamburger, Agnes Eva; Hecht, Randy Ira; Li, Yue-Sheng; Michaels, Mark Leo; Sun, Jeonghoon; Xu, Jing, FGF21 mutant fusion polypeptides and uses thereof.
  343. Belouski, Edward John; Ellison, Murielle Marie; Hamburger, Agnes Eva; Hecht, Randy Ira; Li, Yue-Sheng; Michaels, Mark Leo; Sun, Jeonghoon; Xu, Jing, FGF21 mutants and uses thereof.
  344. Belouski, Edward John; Ellison, Murielle Marie; Hamburger, Agnes Eva; Hecht, Randy Ira; Li, Yue-Sheng; Michaels, Mark Leo; Sun, Jeonghoon; Xu, Jing, FGF21 mutants and uses thereof.
  345. Belouski, Edward John; Ellison, Murielle Marie; Hamburger, Agnes Eva; Hecht, Randy Ira; Li, Yue-Sheng; Michaels, Mark Leo; Sun, Jeonghoon; Xu, Jing, FGF21 mutants comprising a mutation at position 98, 171 and/or 180.
  346. Belouski, Edward John; Ellison, Murielle Marie; Hamburger, Agnes Eva; Hecht, Randy Ira; Li, Yue-Sheng; Michaels, Mark Leo; Sun, Jeonghoon; Xu, Jing, FGF21 mutants multimers and uses thereof.
  347. Belouski, Edward John; Ellison, Murielle Marie; Hamburger, Agnes Eva; Hecht, Randy Ira; Li, Yue-Sheng; Michaels, Mark Leo; Sun, Jeonghoon; Xu, Jing, FGF21 polypeptides comprising two or more mutations.
  348. Belouski, Edward John; Ellison, Murielle Marie; Hamburger, Agnes Eva; Hecht, Randy Ira; Li, Yue-Sheng; Michaels, Mark Leo; Sun, Jeonghoon; Xu, Jing, FGF21 polypeptides comprising two or more mutations and uses thereof.
  349. Robson, Tracy; Valentine, Andrea; O'Rourke, Martin Gerard; Hirst, David, FKBP-L and uses thereof.
  350. Bossard, Mary J.; Stephenson, Gayle, Factor IX moiety-polymer conjugates having a releasable linkage.
  351. DeFrees,Shawn; Zopf,David; Bayer,Robert; Bowe,Caryn; Hakes,David James; Chen,Xi, Factor IX: remolding and glycoconjugation of Factor IX.
  352. DeFrees, Shawn; Zopf, David; Bayer, Robert; Bowe, Caryn; Hakes, David; Chen, Xi, Factor VII: remodeling and glycoconjugation of Factor VII.
  353. Chhabra, Ekta Seth; Liu, Tongyao; Chang, Pei-yun; Peters, Robert T.; Kulman, John, Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereof.
  354. Bossard, Mary J.; Bentley, Michael D.; Zhang, Ping, Factor VIII compositions.
  355. Turecek, Peter; Siekmann, Juergen, Factor VIII polymer conjugates.
  356. Turecek, Peter; Siekmann, Juergen, Factor VIII polymer conjugates.
  357. Turecek, Peter; Siekmann, Juergen, Factor VIII polymer conjugates.
  358. Turecek, Peter; Siekmann, Juergen, Factor VIII polymer conjugates.
  359. Turecek, Peter; Siekmann, Juergen, Factor VIII polymer conjugates.
  360. Turecek, Peter; Siekmann, Juergen, Factor VIII polymer conjugates.
  361. DeFrees,Shawn; Zopf,David; Bayer,Robert; Bowe,Caryn; Hakes,David; Chen,Xi, Factor VIII remodeling and glycoconjugation of Factor VIII.
  362. DeFrees, Shawn; Zopf, David A.; Bayer, Robert J.; Bowe, Caryn; Hakes, David James; Chen, Xi, Factor VIII: remodeling and glycoconjugation of factor VIII.
  363. Turecek, Peter; Siekmann, Juergen; Scheiflinger, Friedrich; Canavaggio, Michel, Factor VIIa-polysialic acid conjugate having prolonged in vivo half-life.
  364. Radhakrishnan, Balasingam; Aggarwal, Diti; Ferro, Michelle; James, Kenneth D.; Malkar, Navdeep B.; Miller, Mark A.; Pavliv, Leo; Polowy, Karen; Puskas, Monica; Ekwuribe, Nnochiri N., Fatty acid formulations and oral delivery of proteins and peptides, and uses thereof.
  365. Radhakrishnan, Balasingam; Aggarwal, Diti; Ferro, Michelle; James, Kenneth D.; Malkar, Navdeep B.; Miller, Mark A.; Pavliv, Leo; Polowy, Karen; Puskas, Monica; Ekwuribe, Nnochiri N., Fatty acid formulations for oral delivery of proteins and peptides, and uses thereof.
  366. Johnson, Leslie S.; Rainey, Godfrey Jonah Anderson; Gorlatov, Sergey; Lerner, Laura, Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use.
  367. Koenig,Scott; Veri,Maria Concetta, FcγRIIB specific antibodies and methods of use thereof.
  368. Koenig,Scott; Veri,Maria Concetta, FcγRIIB-specific antibodies and methods of use thereof.
  369. Johnson, Leslie S.; Huang, Ling, FcγRIIB specific antibodies and methods of use thereof.
  370. Johnson, Leslie S.; Huang, Ling, FcγRIIB specific antibodies and methods of use thereof.
  371. Koenig, Scott; Veri, Maria Concetta, FcγRIIB specific antibodies and methods of use thereof.
  372. Koenig, Scott; Veri, Maria Concetta, FcγRIIB specific antibodies and methods of use thereof.
  373. Koenig, Scott; Veri, Maria Concetta; Tuaillon, Nadine, FcγRIIB specific antibodies and methods of use thereof.
  374. Koenig, Scott; Veri, Maria Concetta; Tuaillon, Nadine; Bonvini, Ezio, FcγRIIB specific antibodies and methods of use thereof.
  375. Koenig, Scott; Veri, Maria Concetta; Tuaillon, Nadine; Bonvini, Ezio, FcγRIIB specific antibodies and methods of use thereof.
  376. Koenig, Scott; Veri, Maria Concetta; Tuaillon, Nadine; Bonvini, Ezio, FcγRIIB specific antibodies and methods of use thereof.
  377. Johnson, Leslie S.; Huang, Ling; Gerena, Robyn, FcγRIIB-specific antibodies and methods of use thereof.
  378. Johnson, Leslie S.; Huang, Ling; Gerena, Robyn, FcγRIIB—specific antibodies and methods of use thereof.
  379. Arvedson, Tara; Dyas, Gregory; Rottman, James B.; Sasu, Barbra; Bi, Xiao-juan; Lee, Grace Ki Jeong; Sheng, Jackie Z., Ferroportin antibodies and methods of use.
  380. Arvedson, Tara; Dyas, Gregory; Rottman, James B.; Sasu, Barbra; Bi, Xiao-juan; Lee, Grace Ki Jeong; Sheng, Jackie Z., Ferroportin antibodies and methods of use.
  381. Hunter Robert L. (3640 Churchwell Ct. Tucker GA 30084) Duncan Alexander (1756 Corners Cove Dunwoody GA 30338), Fibrinolytic composition.
  382. Thomason, Arlen; Liu, Benxian, Fibroblast growth factor-like polypeptides.
  383. Thomason,Arlen Read; Liu,Benxian, Fibroblast growth factor-like polypeptides.
  384. Thomason,Arlen; Liu,Benxian; Danilenko,Dimitry Michael, Fibroblast growth factor-like polypeptides.
  385. Thomason, Arlen; Liu, Benxian, Fibroblast growth factor-like polypeptides and variants thereof.
  386. Thomason, Arlen; Liu, Benxian, Fibroblast growth factor-like polypeptides and variants thereof.
  387. Clark, Richard A.; Ren, Xiang-Dong; Lin, Fubao, Fibronectin polypeptides and methods of use.
  388. Hill, Jennifer J.; Wolfman, Neil M., Follistatin domain containing proteins.
  389. Bandyopadhyay, Sanjay; Natarajan, Venkatesan; Mendiratta, Sanjeev Kumar; Patel, Pankaj Ramanbhai, Formulations of PEG-interferon alpha conjugates.
  390. Bolognesi,Dani Paul; Matthews,Thomas James; Wild,Carl T.; Barney,Shawn O'Lin; Lambert,Dennis Michael; Petteway,Stephen Robert; Langlois,Alphonse J., Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids.
  391. Hill, Jennifer J.; Wolfman, Neil M., GASP1: a follistatin domain containing protein.
  392. Hill, Jennifer J.; Wolfman, Neil M., GASP1: a follistatin domain containing protein.
  393. Hill,Jennifer J.; Wolfman,Neil M., GASP1: a follistatin domain containing protein.
  394. Glaesner, Wolfgang; Mayer, John Philip; Millican, Jr., Rohn Lee; Vick, Andrew Mark; Zhang, Lianshan, GLP-1 pegylated compounds.
  395. DeFrees,Shawn; Zopf,David; Bayer,Robert; Bowe,Caryn; Hakes,David; Chen,Xi, Galactosyl nucleotide sugars.
  396. Chan, Vivien W.; Escobedo, Jaime; Garcia, Pablo Dominguez; Hansen, Rhonda; Kaufmann, Joerg; Kennedy, Giulia C.; Lamson, George; Moler, Edward J.; Randazzo, Filippo; Reinhard, Christoph; Sudduth-Klinger, Julie, Gene products differentially expressed in cancerous cells.
  397. Afar, Daniel E. H.; Raitano, Arthur B.; Hubert, Rene S.; Mitchell, Steve Chappell; Jakobovits, Aya, Gene upregulated in cancers of the prostate.
  398. Afar, Daniel E. H.; Raitano, Arthur B.; Hubert, Rene S.; Mitchell, Steve Chappell; Jakobovits, Aya, Gene upregulated in cancers of the prostate.
  399. Ghaderi, Darius; da Silva, Ana Paula Galvao, Glycan-interacting compounds.
  400. Ghaderi, Darius; da Silva, Ana Paula Galvao, Glycan-interacting compounds.
  401. DeSander, Julie; Behrens, Jeffrey; Lugovskoy, Alexey Alexandrovich, Glycan-interacting compounds and methods of use.
  402. DeFrees,Shawn; Zopf,David; Bayer,Robert; Bowe,Caryn; Hakes,David; Chen,Xi, Glycoconjugates including more than one peptide.
  403. DeFrees,Shawn; Zopf,David; Bayer,Robert; Bowe,Caryn; Hakes,David; Chen,Xi, Glycoconjugation methods and proteins/peptides produced by the methods.
  404. Shorr Robert G. L. (Edison NJ) Cho Myung-Ok (Highland Park NJ) Gilbert Carl W. (Basking Ridge NJ) Ginns Edward J. (Bethesda MD) Martin Brian M. (Rockville MD), Glycolipid enzyme-polymer conjugates.
  405. DeFrees, Shawn; Bayer, Robert J.; Zopf, David A., Glycopegylated erythropoietin.
  406. DeFrees, Shawn; Zopf, David A.; Bowe, Caryn Lang, Glycopegylated erythropoietin.
  407. DeFrees,Shawn; Bayer,Robert J.; Zopf,David A., Glycopegylated erythropoietin.
  408. DeFrees, Shawn; Bayer, Robert J.; Zopf, David A.; Kang, Jichao; Willett, Walter Scott, Glycopegylated erythropoietin formulations.
  409. DeFrees, Shawn; Bayer, Robert J.; Bowe, Caryn L.; Panneerselvam, Krishnasamy, Glycopegylated factor IX.
  410. DeFrees, Shawn; Bayer, Robert J.; Bowe, Caryn; Paneerselvam, Krishnasamy, Glycopegylated factor IX.
  411. DeFrees, Shawn; Bayer, Robert J.; Bowe, Caryn; Panneer-Selvam, Krishnasamy, Glycopegylated factor IX.
  412. DeFrees, Shawn; Clausen, Henrik; Zopf, David A.; Bowe, Caryn; Taudte, Susann; Felo, Michael; Willett, Walter S., Glycopegylated granulocyte colony stimulating factor.
  413. DeFrees, Shawn; Zopf, David A.; Clausen, Henrik; Xing, Ruye, Glycopegylated interferon α.
  414. DeFrees, Shawn; Zopf, David A.; Bayer, Robert J.; Hakes, David James; Bowe, Caryn L.; Chen, Xi, Glycopegylation methods and proteins/peptides produced by the methods.
  415. DeFrees, Shawn; Zopf, David A.; Bayer, Robert J.; Hakes, David James; Bowe, Caryn; Chen, Xi, Glycopegylation methods and proteins/peptides produced by the methods.
  416. DeFrees,Shawn; Zopf,David A.; Bayer,Robert J.; Bowe,Caryn; Hakes,David James; Chen,Xi, Glycopegylation methods and proteins/peptides produced by the methods.
  417. Jain, Sanjay; Gregoriadis, Gregory; Dwivedi, Archana; Nath, Srijit; Siekmann, Juergen; Haider, Stefan; Rottensteiner, Hanspeter; Turecek, Peter, Glycopolysialylation of non-blood coagulation proteins.
  418. Cummings,Richard D.; McEver,Rodger P., Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof.
  419. Cummings,Richard D.; McEver,Rodger P., Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof.
  420. Minami Isao (Osaka JPX) Ueno Hayao (Suita JPX) Fujino Masahiko (Takarazuka JPX), Glycosyl derivatives and use thereof.
  421. DeFrees, Shawn, Glycosylation of peptides via O-linked glycosylation sequences.
  422. DeFrees, Shawn; Zopf, David A.; Bayer, Robert J.; Bowe, Caryn; Hakes, David James; Chen, Xi, Granulocyte colony stimulating factor: remodeling and glycoconjugation G-CSF.
  423. DeFrees,Shawn; Zopf,David; Bayer,Robert; Bowe,Caryn; Hakes,David; Chen,Xi, Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF.
  424. Johnson, Leslie S.; Huang, Ling; Tuaillon, Nadine; Bonvini, Ezio, HER2/neu-specific antibodies and methods of using same.
  425. Johnson, Leslie S.; Huang, Ling; Tuaillon, Nadine; Bonvini, Ezio, HER2/neu-specific antibodies and methods of using same.
  426. Johnson, Leslie S.; Huang, Ling; Tuaillon, Nadine; Bonvini, Ezio, HER2/neu-specific antibodies and methods of using same.
  427. Johnson, Leslie S.; Huang, Ling; Tuaillon, Nadine; Bonvini, Ezio, HER2/neu-specific antibodies and methods of using the same.
  428. Conradt, Harald S.; Grabenhorst, Eckart; Nimtz, Manfred; Zander, Norbert; Frank, Ronald; Eichner, Wolfram, Hasylated polypeptides.
  429. Iwasaki Keiji (Kawasaki JPX) Iwashita Yuji (Kawasaki JPX) Okami Taketoshi (Yokohama JPX), Hemoglobin combined with a poly(alkylene oxide).
  430. Acharya A. Seetharama (Cresskill NJ) Manjula Belur N. (Cresskill NJ) Smith Paul K. (Roscoe IL), Hemoglobin crosslinkers.
  431. Sasu, Barbra; Haniu, Mitsuru; Boone, Thomas Charles; Bi, Xiao-juan; Lee, Grace Ki Jeong; Arvedson, Tara; Winters, Aaron George; Cooke, Keegan; Sheng, Jackie Z., Hepcidin, hepcidin antagonists and methods of use.
  432. Bentley, Michael D.; Harris, J. Milton; Kozlowski, Antoni, Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation.
  433. Bentley, Michael D.; Harris, J. Milton; Kozlowski, Antoni, Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation.
  434. Bentley, Michael D.; Harris, J. Milton; Kozlowski, Antoni, Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation.
  435. Bentley, Michael David; Harris, J. Milton; Kozlowski, Antoni, Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation.
  436. Michael David Bentley ; J. Milton Harris ; Antoni Kozlowski, Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation.
  437. Moore, Gregory; Desjarlais, John; Chu, Seung, Heterodimeric antibodies that bind CD3 and PSMA.
  438. Bernett, Matthew J.; Moore, Gregory; Desjarlais, John; Chu, Seung; Rashid, Rumana; Muchhal, Umesh; Lee, Sung-Hyung, Heterodimeric antibodies that bind CD3 and tumor antigens.
  439. Bernett, Matthew J.; Moore, Gregory; Desjarlais, John; Chu, Seung; Rashid, Rumana; Muchhal, Umesh; Lee, Sung-Hyung, Heterodimeric antibodies to CD3 X CD123.
  440. Bernett, Matthew J.; Moore, Gregory; Desjarlais, John; Chu, Seung; Rashid, Rumana; Muchhal, Umesh; Lee, Sung-Hyung, Heterodimeric antibodies to CD3 X CD20.
  441. Desjarlais, John R.; Moore, Gregory L.; Rashid, Rumana; Bernett, Matthew J., Heterodimeric proteins.
  442. Moore, Gregory; Bernett, Matthew; Desjarlais, John; Rashid, Rumana, Heterodimeric proteins.
  443. Moore, Gregory; Bernett, Matthew; Rashid, Rumana; Desjarlais, John, Heterodimeric proteins.
  444. Moore, Gregory; Rashid, Rumana; Desjarlais, John, Heterodimeric proteins.
  445. Greenwald Richard B. ; Pendri Annapurna, High molecular weight polymer-based prodrugs.
  446. Greenwald Richard B. ; Pendri Annapurna ; Zhao Hong, High molecular weight polymer-based prodrugs.
  447. Obermeier Rainer (Hattersheim DEX) Ludwig Jurgen (Brachttal DEX) Tripier Dominique (Eppstein DEX) Hropot Max (Florsheim DEX), Hirudin derivatives and a process for their preparation.
  448. Fachini, Roger; Foltz, Ian; Han, Seog Joon; Harris, Susie Miki; Hu, Shaw-Fen Sylvia; King, Chadwick Terence; Li, Yang; Lu, Ji; Michaels, Mark Leo; Sun, Jeonghoon, Human FGF receptor and β-Klotho binding proteins.
  449. Li, Yi, Human G-protein chemokine receptor HSATU68.
  450. Boyle, William J.; Medlock, Eugene; Sullivan, John J.; Elliott, Robin L.; Martin, Frank; Huang, Haichun, Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors.
  451. Boyle, William J.; Medlock, Eugene; Sullivan, John K.; Elliott, Robin L.; Martin, Frank; Huang, Haichun, Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors.
  452. Boyle, William J.; Medlock, Eugene; Sullivan, John K.; Elliott, Robin L.; Martin, Frank; Huang, Haichun, Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors.
  453. Masat, Linda; Roell, Marina, Human antibodies specific for gastrin materials and methods.
  454. Hu, Shaw-Fen Sylvia; Foltz, Ian; King, Chadwick Terence; Li, Yang; Arora, Taruna, Human antigen binding proteins that bind β-Klotho, FGF receptors and complexes thereof.
  455. Hu, Shaw-Fen Sylvia; Foltz, Ian Nevin; King, Chadwick Terence; Li, Yang; Arora, Taruna, Human antigen binding proteins that bind β-klotho, FGF receptors and complexes thereof.
  456. Koh, Hyung Kon, Human granulocyte-colony stimulating factor isoforms.
  457. Sutkowski, Natalie; Fernandes, Daniel; Hoel, Brian; Rubinchik, Semyon, Human monoclonal antibodies to human nucleolin.
  458. Johnson, Leslie S.; Huang, Ling, Humanized FcγRIIB-specific antibodies and methods of use thereof.
  459. Johnson, Leslie S.; Huang, Ling, Humanized FcγRIIB-specific antibodies and methods of use thereof.
  460. Johnson, Leslie S.; Huang, Ling, Humanized FcγRIIB-specific antibodies and methods of use thereof.
  461. Lee, Renata; Mikol, Vincent; Allen, Elizabeth; Ruetsch, Norman; Cameron, Beatrice; Oligino, Thomas; Baurin, Nicholas, Humanized anti-CXCR5 antibodies, derivatives thereof and their use.
  462. Lee, Renata; Mikol, Vincent; Allen, Elizabeth; Ruetsch, Norman; Cameron, Beatrice; Oligino, Thomas; Baurin, Nicholas, Humanized anti-CXCR5 antibodies, derivatives thereof and their use.
  463. Lee, Renata; Mikol, Vincent; Allen, Elizabeth; Ruetsch, Norman; Cameron, Beatrice; Oligino, Thomas; Baurin, Nicholas, Humanized anti-CXCR5 antibodies, derivatives thereof and their use.
  464. Lee, Renata; Mikol, Vincent; Allen, Elizabeth; Ruetsch, Norman; Cameron, Beatrice; Oligino, Thomas; Baurin, Nicholas, Humanized anti-CXCR5 antibodies, derivatives thereof and their use.
  465. Lee, Renata; Mikol, Vincent; Allen, Elizabeth; Ruetsch, Norman; Cameron, Beatrice; Oligino, Thomas; Baurin, Nicolas, Humanized anti-CXCR5 antibodies, derivatives thereof and their use.
  466. Lee, Renata; Mikol, Vincent; Allen, Elizabeth; Ruetsch, Norman; Cameron, Beatrice; Oligino, Thomas; Baurin, Nicholas, Humanized anti-CXCR5 antibodies, derivatives thereof and their uses.
  467. Sabbadini, Roger A.; Garland, William A.; Hansen, Genevieve; Jones, Steven Tarran; Williams, David Gareth, Humanized antibodies and compositions for binding sphingosine-1-phosphate.
  468. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Hyaluronidase and factor VIII compositions.
  469. Kudirka, Romas Alvydas; Albers, Aaron Edward; Barfield, Robyn M.; Rabuka, David, Hydrazinyl-indole compounds and methods for producing a conjugate.
  470. Kudirka, Romas Alvydas; Albers, Aaron Edward; Barfield, Robyn M.; Rabuka, David, Hydrazinyl-indole compounds and methods for producing a conjugate.
  471. Kozlowski, Antoni; Gross, III, Remy F.; McManus, Samuel P., Hydrolytically stable maleimide-terminated polymers.
  472. Kozlowski, Antoni; Gross, III, Remy F.; McManus, Samuel P., Hydrolytically stable maleimide-terminated polymers.
  473. Kozlowski, Antoni; Gross, III, Remy F.; McManus, Samuel P., Hydrolytically stable maleimide-terminated polymers.
  474. Kozlowski,Antoni; Gross, III,Remy F.; McManus,Samuel P., Hydrolytically stable maleimide-terminated polymers.
  475. Kozlowski,Antoni; Gross, III,Remy F.; McManus,Samuel P., Hydrolytically stable maleimide-terminated polymers.
  476. Ekwuribe Nnochiri Nkem ; Ramaswamy Muthukumar ; Radhakrishnan Balasingam ; Allaudeen HameedSulthan S., Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin.
  477. Rasmussen, Daniel E.; Krarup, Janus, Hydrophobic interaction chromatography purification of factor VII polypeptides.
  478. Zander, Norbert; Conradt, Harald S.; Eichner, Wolfram, Hydroxyalkyl starch derivatives.
  479. Zander, Norbert; Conradt, Harald; Eichner, Wolfram, Hydroxyalkyl starch derivatives.
  480. Hacket, Frank; Hey, Thomas; Hauschild, Franziska; Knoller, Helmut; Schimmel, Martin; Sommermeyer, Klaus, Hydroxyalkyl starch derivatives and process for their preparation.
  481. Shepard, H. Michael; Li, Xiaoming; Thompson, Curtis, Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods.
  482. Grizot, Sylvestre, I-CreI derived single-chain meganuclease and uses thereof.
  483. Basile, Lena A., IL-12 for radiation protection and radiation-induced toxicity mitigation.
  484. Basile, Lena A., IL-12 formulations for enhancing hematopoiesis.
  485. Scheer, Justin; Ouyang, Wenjun; Vandlen, Richard; Hass, Philip E.; Stefanich, Eric Gary; Wang, Xiaoting, IL-22 Fc fusion proteins.
  486. Stavenhagen, Jeffrey; Vijh, Sujata; Rankin, Christopher; Gorlatov, Sergey; Huang, Ling, Identification and engineering of antibodies with variant FC regions and methods of using same.
  487. Stavenhagen, Jeffrey B.; Vijh, Sujata; Rankin, Christopher, Identification and engineering of antibodies with variant Fc regions and methods of using same.
  488. Stavenhagen, Jeffrey B.; Vijh, Sujata; Rankin, Christopher; Gorlatov, Sergey; Huang, Ling, Identification and engineering of antibodies with variant Fc regions and methods of using same.
  489. Stavenhagen, Jeffrey; Gorlatov, Sergey; Rankin, Christopher; Tuaillon, Nadine, Identification and engineering of antibodies with variant Fc regions and methods of using same.
  490. Stavenhagen, Jeffrey; Vijh, Sujata; Rankin, Christopher; Gorlatov, Sergey; Huang, Ling, Identification and engineering of antibodies with variant Fc regions and methods of using same.
  491. Koren, Eugen; Lowe, John Hok Nin, Identification and modification of immunodominant epitopes in polypeptides.
  492. Thomason, Arlen Read; Liu, Benxian, Identifying modulators of fibroblast growth factor-like polypeptides.
  493. Eveleigh John W. D. (Amherst NH), Immobilization of biomolecules on perfluorocarbon surfaces.
  494. Lazar, Gregory Alan; Dahiyat, Bassil I.; Dang, Wei; Karki, Sher Bahadur; Vafa, Omid, Immunoglobulin insertions, deletions, and substitutions.
  495. Lydon, Nicholas B., Immunoglobulins and variants directed against pathogenic microbes.
  496. Lydon, Nicholas B., Immunoglobulins and variants directed against pathogenic microbes.
  497. Lazar, Gregory; Dahiyat, Bassil; Dang, Wei; Karki, Sher Bahadur; Vafa, Omid, Immunoglobulins insertions, deletions, and substitutions.
  498. Hanai Nobuo,JPX ; Furuya Akiko,JPX ; Yamasaki Motoo,JPX ; Kobayashi Satoshi,JPX ; Kuwabara Takashi,JPX, Immunological assay for quantifying peg-modified human granulocyte colony stimulating factor and monoclonal antibodies.
  499. Mezo, Adam R.; McDonnell, Kevin A., Immunomodulatory peptides.
  500. Magruder Judy A. (Mt. View CA) Eckenhoff ; deceased James B. (late of Los Altos CA by Bonnie J. Eckenhoff ; executrix ) Cortese Richard (Los Gatos CA) Wright Jeremy C. (Los Altos CA) Peery John R. (S, Implantable system for delivery of fluid-sensitive agents to animals.
  501. Magruder Judy A. ; Eckenhoff ; deceased James B. ; Cortese Richard ; Wright Jeremy C. ; Peery John R. ; Pike James B. ; Robinson Urano A. ; Smith Jonathan P. ; Ziemann Lyle E., Implantable system for delivery of fluid-sensitive agents to animals.
  502. Hunter Robert L. (Tucker GA) Duncan Alexander (Dunwoody GA), Improved method of performing angioplasty procedures.
  503. Adams,Camellia W.; Ashkenazi,Avi J.; Chuntharapai,Anan; Kim,Kyung Jin, Inducing apoptosis using anti-Apo-2 antibodies.
  504. Johnson,Howard M.; Subramaniam,Prem S.; Mujtaba,Mustafa G.; Flowers,Lawrence, Inhibitors of autophosphorylation protein kinases.
  505. Sadhu, Chanchal; Dick, Ken; Treiberg, Jennifer; Sowell, C. Gregory; Kesicki, Edward A.; Oliver, Amy, Inhibitors of human phosphatidylinositol 3-kinase delta.
  506. Sadhu, Chanchal; Dick, Ken; Treiberg, Jennifer; Sowell, C. Gregory; Kesicki, Edward A.; Oliver, Amy, Inhibitors of human phosphatidylinositol 3-kinase delta.
  507. Sadhu, Chanchal; Dick, Ken; Treiberg, Jennifer; Sowell, C. Gregory; Kesicki, Edward A.; Oliver, Amy, Inhibitors of human phosphatidylinositol 3-kinase delta.
  508. Sadhu, Chanchal; Dick, Ken; Treiberg, Jennifer; Sowell, C. Gregory; Kesicki, Edward A.; Oliver, Amy, Inhibitors of human phosphatidylinositol 3-kinase delta.
  509. Sadhu, Chanchal; Dick, Ken; Treiberg, Jennifer; Sowell, C. Gregory; Kesicki, Edward A.; Oliver, Amy, Inhibitors of human phosphatidylinositol 3-kinase delta.
  510. Sadhu, Chanchal; Dick, Kenneth O.; Treiberg, Jennifer; Sowell, C. Gregory; Kesicki, Edward A.; Oliver, Amy, Inhibitors of human phosphatidylinositol 3-kinase delta.
  511. Sadhu, Chanchal; Dick, Kennith O.; Treiberg, Jennifer; Sowell, C. Gregory; Kesicki, Edward A.; Oliver, Amy, Inhibitors of human phosphatidylinositol 3-kinase delta.
  512. Li, Jun; Yu, Hanry; Leong, Kam, Injectable drug delivery systems with cyclodextrin-polymer based hydrogels.
  513. Ekwuribe,Nnochiri N.; Price,Christopher H.; Still,James Gordon; Filbey,Jennifer Ann; Ansari,Aslam M.; Odenbaugh,Amy L.; Radhakrishnan,Balasingam, Insulin conjugates for treating diabetes mellitus.
  514. Kodra, Janos Tibor; Garibay, Patrick William; Hoeg-Jensen, Thomas; Jonassen, Ib; Madsen, Peter; Tagmose, Tina Moeller, Insulin derivatives.
  515. Kodra, János Tibor; Garibay, Patrick William; Hoeg-Jensen, Thomas; Jonassen, Ib; Madsen, Peter; Møller Tagmose, Tina, Insulin derivatives.
  516. Kodra, János Tibor; Garibay, Patrick William; Hoeg-Jensen, Thomas; Tagmose, Tina, Insulin derivatives.
  517. Naver, Helle; Schlein, Morten; Steensgaard, Dorte Bjerre; Petterson, Ingrid Vivika, Insulin formulations.
  518. Radhakrishnan,Balasingam; Soltero,Richard; Ekwuribe,Nnochiri N.; Puskas,Monica; Sangal,Diti, Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same.
  519. Soltero,Richard; Radhakrishnan,Balasingam; Ekwuribe,Nnochiri N., Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same.
  520. Ekwuribe,Nnochiri N.; Ramaswamy,Muthukumar; Rajagopalan,Jayanthi, Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin.
  521. Soliman, Tarik; Hales, Laura M.; Hall, Daniel B.; Sard, Howard; Hegde, Vishnumurthy, Insulin vitamin D conjugates.
  522. Radhakrishnan, Balasingam; Aggarwal, Diti; Ferro, Michelle; James, Kenneth D.; Malkar, Navdeep B.; Miller, Mark A.; Puskas, Monica E.; Ekwuribe, Nnochiri N., Insulin-oligomer conjugates, formulations and uses thereof.
  523. Radhakrishnan, Balasingam; Aggarwal, Diti; Ferro, Michelle; James, Kenneth D.; Malkar, Navdeep B.; Miller, Mark A.; Puskas, Monica; Ekwuribe, Nnochiri N., Insulin-oligomer conjugates, formulations and uses thereof.
  524. Zhou, Weidong; Xiao, Qingjiang; Sun, Li; Wang, Tiebing; Yin, Fenghong; Luo, Shihong; Zhuang, Lu; Liu, Min; Xu, Tianle; Zhang, Yong, Interferon alpha-2B modified by polyethylene glycol and methods of preparation thereof.
  525. Zhou, Weidong; Xiao, Qingjiang; Sun, Li; Wang, Tiebing; Liu, Bin; Lin, Song; Liu, Min; Yin, Fenghong; Zhuang, Lu; Lei, Lifang, Interferon alpha-2a modified by polyethylene glycol and methods of preparation thereof.
  526. DeFrees,Shawn; Zopf,David; Bayer,Robert; Bowe,Caryn; Hakes,David; Chen,Xi, Interferon alpha: remodeling and glycoconjugation of interferon alpha.
  527. DeFrees,Shawn; Zopf,David; Bayer,Robert; Bowe,Caryn; Hakes,David; Chen,Xi, Interferon beta: remodeling and glycoconjugation of interferon beta.
  528. Gilbert Carl W. ; Cho Myung-Ok, Interferon polymer conjugates.
  529. Gilbert Carl W. ; Park-Cho Myung-ok,KRX, Interferon polymer conjugates.
  530. Greenwald Richard B. ; Gilbert Carl W., Interferon polymer conjugates and process for preparing the same.
  531. Whitty, Adrian; Runkel, Laura; Brickelmaier, Margot; Hochman, Paula, Interferon-beta fusion proteins and uses.
  532. Whitty, Adrian; Runkel, Laura; Brickelmaier, Margot; Hochman, Paula, Interferon-beta-1a-immunoglobulin fusion proteins and uses.
  533. Juan, Shao-Chieh; Fletcher, Frederick A.; Patterson, Scott D., Interleukin-1.beta. converting enzyme like cysteine protease.
  534. Brakenhoff Just P. J. (Amsterdam NLX) Aarden Lucien A. (Broek in Waterland NLX), Interleukin-6 receptor antagonists.
  535. McManus, Samuel P.; Kozlowski, Antoni; Hutchison, Tracy L.; Bray, Brian; Shen, Xiaoming, Intermediates useful in the preparation of maleimide functionalized polymers.
  536. McManus, Samuel P.; Kozlowski, Antoni; Hutchison, Tracy L.; Bray, Brian; Shen, Xiaoming, Intermediates useful in the preparation of maleimide functionalized polymers.
  537. McManus, Samuel P.; Kozlowski, Antoni; Hutchison, Tracy L.; Bray, Brian; Shen, Xiaoming, Intermediates useful in the preparation of maleimide functionalized polymers.
  538. McManus, Samuel P.; Kozlowski, Antoni; Hutchison, Tracy L.; Bray, Brian; Shen, Xiaoming, Intermediates useful in the preparation of maleimide functionalized polymers.
  539. DeFrees, Shawn, Intracellular formation of peptide conjugates.
  540. Rubsamen Reid M., Intrapulmonary delivery of hematopoietic drug.
  541. Harris J. Milton, Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for m.
  542. Harris J. Milton, Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for m.
  543. Harris,J. Milton, Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules.
  544. Barney, Shawn O'Lin; Lambert, Dennis Michael; Petteway, Stephen Robert, Isolated peptides derived from human immunodeficiency virus types 1 and 2 containing fusion inhibitory domains.
  545. Kambadur, Ravi; Sharma, Mridula; Senna Salerno De Moura, Monica; Berry, Carole J.; Siriett, Victoria; Bower, Robert Syndecombe; Nicholas, Gina Diane; McFarlane, Craig Desmond, Isolated polypeptides and methods of improving muscle strength.
  546. Pennica, Diane; Smith, Victoria; Wood, William I., Isolated stra6 polypeptides.
  547. Blair, Henry; Beck, Thomas; Ladner, Robert C., Kallikrein inhibitors and anti-thrombolytic agents and uses thereof.
  548. Blair, Henry; Beck, Thomas; Ladner, Robert C., Kallikrein inhibitors and anti-thrombolytic agents and uses thereof.
  549. Blair, Henry; Beck, Thomas; Ladner, Robert Charles, Kallikrein inhibitors and anti-thrombolytic agents and uses thereof.
  550. Blair,Henry; Beck,Thomas; Ladner,Robert C., Kallikrein inhibitors and anti-thrombolytic agents and uses thereof.
  551. Markland William ; Ladner Robert Charles, Kallikrein-binding "Kunitz domain" proteins and analogues thereof.
  552. Markland William ; Ladner Robert Charles, Kallikrein-binding "Kunitz domain" proteins and analogues thereof.
  553. Markland, William; Ladner, Robert C., Kallikrein-binding "Kunitz domain" proteins and analogues thereof.
  554. Markland, William; Ladner, Robert C., Kallikrein-binding “Kunitz domain” proteins and analogues thereof.
  555. Markland, William; Ladner, Robert C., Kallikrein-binding “kunitz domain” proteins and analogues thereof.
  556. Markland Willaim ; Ladner Robert Charles, Kallikrein-inhibiting "Kunitz Domain" proteins and analogues thereof.
  557. Markland Willaim ; Ladner Robert Charles, Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof.
  558. Ladner, Robert C.; Ley, Arthur C.; Hirani, Shirish; Williams, Anthony, Kallikrein-inhibitor therapies.
  559. Ladner, Robert C.; Ley, Arthur C.; Hirani, Shirish; Williams, Anthony; Grazia De Simoni, Maria; Bergamaschini, Luigi, Kallikrein-inhibitor therapies.
  560. Ladner, Robert C.; Ley, Arthur C.; Hirani, Shirish; Williams, Anthony; Simoni, Maria Grazia; Bergamaschini, Luigi, Kallikrein-inhibitor therapies.
  561. Ladner,Robert C.; Ley,Arthur C.; Hirani,Shirish; Williams,Anthony; De Simoni,Maria Grazia; Bergamaschini,Luigi, Kallikrein-inhibitor therapies.
  562. Braun,Andreas; Cantor,Charles R.; Kammerer,Stefan M.; Taylor,Susan; Burns Hamuro,Lora; Cook,Charles; Olson,Gary; Self,Christopher, Kinase anchor protein muteins, peptides thereof and related documents.
  563. Daniloff, George Y.; Ngo, Michael Huy; Trollsas, Olof Mikael; Gravett, David M.; Toleikis, Philip M., Kit for multifunctional compounds forming crosslinked biomaterials.
  564. Sparks,Mary Jean; Huang,Wenhu, Knockout animals manifesting hyperlipidemia.
  565. Huang,Shi Kun; Zalipsky,Samuel; Zhang,Wei Ming, Liposome composition for delivery of nucleic acid.
  566. Hinderer, Walter; Scheckermann, Christian, Liquid formulation of G-CSF conjugate.
  567. Reslow, Mats, Liquid formulations N-terminal serine of pegylated growth hormone.
  568. Nordkild, Peter; Lindenberg, Svend; Andersen, Claus Yding; Andersen, Kim Vilbour, Long acting biologically active luteinizing hormone (LH) compound.
  569. Hiratani Hajime (Sennan JPX), Long-acting composition.
  570. Lustbader, Joyce, Long-acting follicle stimulating hormone analogues and uses thereof.
  571. Lustbader,Joyce; Lobel,Leslie, Long-acting hormone and growth factor compositions and uses thereof.
  572. Lustbader,Joyce; Lobel,Leslie, Long-acting hormone and growth factor compositions and uses thereof.
  573. Wu, Han-Chung; Lin, Chin-Tarng; Chang, De-Kuan, Lung cancer-targeted peptides and applications thereof.
  574. Callahan, William J.; Remmele, Jr., Richard L.; Ratnaswamy, Gayathri; Latypov, Ramil F.; Liu, Dingjiang, Lyophilized therapeutic peptibody formulations.
  575. Callahan, William J.; Remmele, Jr., Richard L.; Ratnaswamy, Gayathri; Latypov, Ramil F.; Liu, Dingjiang, Lyophilized therapeutic peptibody formulations.
  576. Shayman, James A.; Abe, Akira; Kelly, Robert; Kollmeyer, Jessica; Lu, Ye, Lysosomal phospholipase A2 (LPLA2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis.
  577. Shayman, James A.; Abe, Akira; Kelly, Robert; Kollmeyer, Jessica; Lu, Ye, Lysosomal phospholipase A2 (LPLA2) activity as a therapeutic target for treating systemic lupus erythematosus.
  578. Kavanaugh, William M.; Aukerman, Lea; Sung, Victoria, M-CSF-specific monoclonal antibody and uses thereof.
  579. Barnikol, Wolfgang, Mammalian haemoglobin compatible with blood plasma, cross-linked and conjugated with polyalkylene oxides as artificial medical oxygen carriers, production and use thereof.
  580. Koppaka, Vish; Vellard, Michel Claude; Okhamafe, Augustus O.; Araya, Kidisti, Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof.
  581. Koppaka, Vish; Vellard, Michel Claude; Okhamafe, Augustus O.; Araya, Kidisti, Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof.
  582. Koppaka, Vish; Vellard, Michel Claude; Okhamafe, Augustus; Araya, Kidisti, Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof.
  583. Siekmann, Juergen; Sheinecker, Richard; Rottensteiner, Hanspeter; Turecek, Peter, Materials and methods for conjugating a water soluble fatty acid derivative to a protein.
  584. Hinds, Kenneth; Lewis, Danny; Schmidt, Paul; Campbell, Kathleen M., Materials and methods for preparing protein-polymer conjugates.
  585. Garnett, Martin Charles; Davis, Stanley Stewart; Bignotti, Fabio; Ferruti, Paolo, Method for attaching polyethylene glycol to macromolecules.
  586. Chen, Tingchao; Zhao, Yi; Anderson, W. French, Method for bone marrow preservation or recovery.
  587. Frost, Gregory I.; Bilinsky, Igor; Vaughn, Daniel; Sugarman, Barry, Method for control of post-prandial glucose.
  588. Yano, Kazuki; Kobayashi, Fumie; Goto, Masaaki; Washida, Naohiro; Tsuda, Eisuke; Higashio, Kanji; Yamada, Yoshiji, Method for diagnosing bone dysbolism.
  589. Havelund, Svend; Jensen, Simon Bjerregaard, Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein.
  590. Drummond, Robert J.; Rosenberg, Steve, Method for increasing the serum half-life of a biologically active molecule.
  591. Drummond,Robert J.; Rosenberg,Steve, Method for increasing the serum half-life of a biologically active molecule.
  592. Robert J. Drummond ; Steve Rosenberg, Method for increasing the serum half-life of a biologically active molecule.
  593. Winslow, Robert M.; Vandegriff, Kim D., Method for making a high oxygen affinity modified hemoglobin for oxygen transport.
  594. Barnikol Wolfgang,DEX, Method for obtaining uniform fractions of hyperpolymeric hemoglobins.
  595. Harris, J. Milton; Kozlowski, Antoni; McManus, Samuel P.; Bentley, Michael D.; Charles, Stephen A., Method for preparing a polymeric reagent.
  596. Kozlowski, Antoni; Handley, John; Schaefer, Anthony G.; Bray, Brian; Odom, Ryan; Sander, Tony L., Method for preparing conjugates using polymer maleimides.
  597. Kozlowski, Antoni; Handley, John R.; Schaefer, Anthony G.; Bray, Brian; Odom, Ryan; Sander, Tony L., Method for preparing polymer maleimides.
  598. Kozlowski, Antoni; Handley, John; Schaefer, Anthony G.; Bray, Brian; Odom, Ryan; Sander, Tony L., Method for preparing polymer maleimides.
  599. Rhee, Woonza M.; DeLustro, Frank A.; Berg, Richard A., Method for preventing the formation of adhesions following surgery or injury.
  600. Harris,J. Milton; Veronese,Francesco Maria; Caliceti,Paola; Schiavon,Oddone, Method for purifying a branched water-soluble polymer.
  601. Sherman, Merry R.; Saifer, Mark G. P.; Williams, L. David; Hershfield, Michael S.; Kelly, Susan J., Method for purifying urate oxidase tetramers and octamers.
  602. Olsen Arne Agerlin,DKX ; Hansen Lars Bo,DKX ; Beck Thomas Christian,DKX, Method for reducing respiratory allergenicity.
  603. Buchardt, Jens; Langeland Johansen, Nils, Method for selectively modifying a protein via transglutaminase catalyzed reaction.
  604. Duchateau, Philippe; Valton, Julien; Bertonati, Claudia; Epinat, Jean-Charles; Silva, George H.; Juillerat, Alexandre; Beurdeley, Marine, Method for the generation of compact TALE-nucleases and uses thereof.
  605. Boehm, Gerald; Esser, Dirk, Method for transfer of molecular substances with prokaryotic nucleic acid-binding proteins.
  606. Boehm,Gerald; Esser,Dirk, Method for transfer of molecular substances with prokaryotic nucleic acid-binding proteins.
  607. Chen, Tingchao; Zhao, Yi; Anderson, W. French, Method for treating deficiency in hematopoiesis.
  608. Zalipsky,Samuel; Gabizon,Alberto, Method for treating multi-drug resistant tumors.
  609. Rhee, Woonza M.; DeLustro, Frank A.; Berg, Richard A., Method for treating or inhibiting the formation of adhesions following surgery or injury.
  610. Stevens Vernon C., Method for treatment of antigenically modified polypeptides.
  611. Stevens Vernon C., Method for treatment of antigenically modified polypeptides.
  612. Stevens Vernon C. (Dublin OH), Method for treatment of antigenically modified polypeptides.
  613. Creasey Abla A. ; Broze George J., Method for using lipoprotein associated coagulation inhibitor to treat sepsis.
  614. Creasey, Abla A.; Broze, George J., Method for using lipoprotein associated coagulation inhibitor to treat sepsis.
  615. Hunter Robert L. (Tucker GA), Method of delivering drugs to damaged or diseased tissue.
  616. Yano,Kazuki; Kobayashi,Fumie; Goto,Masaaki; Washida,Naohiro; Tsuda,Eisuke; Higashio,Kaoji; Yamada,Yoshiji, Method of diagnosing metabolic bone diseases.
  617. Huang, Jung San; Huang, Shuan Shian, Method of enhancing TGF-β signalling.
  618. Matthews William ; Austin Timothy W., Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides.
  619. Ranade,Koustubh; Delmonte,Terrye Aigeldinger; Geese,William J., Method of identifying a PPARgamma-agonist compound having a decreased likelihood of inducing dose-dependent peripheral edema.
  620. Basile, Lena A., Method of increasing survival of a human subject having exposure to an acute exposure to non-therapeutic whole body ionization by administering a therapeutically effective dose of IL-12.
  621. Rhee Woonza M. ; DeLustro Frank A. ; Berg Richard A., Method of making crosslinked polymer matrices in tissue treatment applications.
  622. Weiss, Stephen J.; Rowe, Robert G., Method of modulating neovascularization.
  623. McManus, Samuel P.; Kozlowski, Antoni; Hutchison, Tracy L.; Bray, Brian; Shen, Xiaoming, Method of preparing maleimide functionalized polymers.
  624. Zhao,Hong; Rubio,Belen; Xia,Jing, Method of preparing polymers having terminal amine groups.
  625. Shayman, James A.; Abe, Akira; Kelly, Robert; Kollmeyer, Jessica; Lu, Ye, Method of reducing accumulation of intracellular tingible body macrophages.
  626. Goldenberg David M. (Short Hills NJ), Method of reducing immunogenicity.
  627. Hunter Robert L. (Tucker GA), Method of treating adult respiratory distress syndrome.
  628. Hunter Robert L. (Tucker GA), Method of treating burns.
  629. Waldman, Scott A.; Magee, Michael S.; Snook, Adam E., Method of treating cancer by administering chimeric antigen receptor comprising anti-GCC antibody.
  630. Klima,Horst; Lehmann,Paul; Roeddiger,Ralf; Walter Matsui,Ruth, Method of treating disturbances of iron distribution in inflammatory intestinal diseases.
  631. Sexton, Daniel J.; Viswanathan, Malini, Method of treating hereditary angioedema using plasma kallikrein binding antibodies.
  632. Hunter Robert L. (Tucker GA), Method of treating mycardial damage.
  633. Hunter Robert L. (Tucker GA), Method of treating tissue damaged by reperfusion injury.
  634. Bentires-Alj, Mohamed; Aceto, Nicola; Stadler, Michael, Method of treatment of breast cancers over-expressing the SHP2 signature genes.
  635. Clark,Mike A., Method of treatment with modified arginine deiminase.
  636. Rhee Woonza M. ; DeLustro Frank A. ; Berg Richard A., Method of using crosslinked polymer compositions in tissue treatment applications.
  637. Kim, Sung K.; Deciu, Cosmin, Methods and compositions for analyzing nucleic acid.
  638. Lewis, Danny; Schmidt, Paul; Hinds, Kenneth, Methods and compositions for enhanced delivery of bioactive molecules.
  639. Robert M. Winslow, Methods and compositions for optimization of oxygen transport by cell-free systems.
  640. Winslow Robert M., Methods and compositions for optimization of oxygen transport by cell-free systems.
  641. Winslow,Robert M., Methods and compositions for optimization of oxygen transport by cell-free systems.
  642. Sukhatme, Vikas P.; Zon, Leonard I.; Galloway, Jenna, Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders.
  643. Hunter Robert L. (Tucker GA), Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids.
  644. Chevrier, Marc; Freimuth, William W.; Zhong, Zhenshao; Odenheimer, Daniel, Methods and compositions for use in treatment of patients with autoantibody positive disease.
  645. Martin, Flavius, Methods and compositions related to B cell assays.
  646. Rosario-Jansen, Theresa; Wright, David Erick, Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy.
  647. Cantor, Charles R.; DeSantis, Grace; Mueller, Reinhold; Ehrich, Mathias, Methods and processes for non-invasive assessment of genetic variations.
  648. Donnelly, Mark; Eschenfeldt, William H.; Trent, Jonathan, Methods for converting glucose to ascorbic acid.
  649. Sabbadini, Roger A., Methods for decreasing immune response and treating immune conditions.
  650. Ekwuribe, Nnochiri N.; Rhadakrishnan, Balasingam; Price, Christopher H.; Anderson Jr., Wes; Ansari, Adam M., Methods for delivering therapeutics across blood-barrier and for altering receptor binding affinity.
  651. Ekwuribe, Nnochiri N.; Rhadakrishnan, Balasingam; Price, Christopher H.; Anderson, Jr., Wes; Ansari, Aslam M., Methods for delivery therapeutic compounds across the blood-brain barrier.
  652. Harris, J. Milton; Kozlowski, Antoni; McManus, Samuel P.; Bentley, Michael D.; Charles, Stephen A., Methods for forming polymer-drug conjugates.
  653. Braun, Andreas; Koster, Hubert; Van den Boom, Dirk; Yip, Ping; Rodi, Charles; He, Liyan; Chiu, Norman; Jurinke, Christiane, Methods for generating databases and databases for identifying polymorphic genetic markers.
  654. Braun, Andreas; Köster, Hubert; Van Den Boom, Dirk Johannes; Yip, Ping; Rodi, Charles; He, Liyan; Chiu, Norman; Jurinke, Christian, Methods for generating databases and databases for identifying polymorphic genetic markers.
  655. Köster, Hubert; Braun, Andreas; Van Den Boom, Dirk; Ping, Yip; Rodi, Charlie; He, Liyan; Chiu, Norman; Jurinke, Christian, Methods for generating databases and databases for identifying polymorphic genetic markers.
  656. Young, Andrew A.; Gedulin, Bronislava, Methods for glucagon suppression.
  657. Young,Andrew A.; Gedulin,Bronislava, Methods for glucagon suppression using modified exendins.
  658. Young,Andrew A.; Gedulin,Bronislava, Methods for glucagon suppression using modified exendins.
  659. Yamaguchi,Kyoji; Yasuda,Hisataka; Nakagawa,Nobuaki; Shima,Nobuyuki; Kinosaki,Masahiko; Tsuda,Eisuke; Goto,Masaaki; Yano,Kazuki; Tomoyasu,Akihiro; Kobayashi,Fumie; Washida,Naohiro; Takahashi,Ken; Mori, Methods for identifying a substance which specifically binds to an osteoclastogenesis inhibitory factor-binding molecule and modulates the biological activity thereof.
  660. Huang, Shuan Shian; Huang, Jung San, Methods for inhibiting TGF-β.
  661. Clark,Mike, Methods for inhibiting viral replication in vivo.
  662. Anderson, Dirk M, Methods for interfering with rank signaling.
  663. Hartman, Jacob; Mendelovitz, Simona; Rehrig, Claudia D.; Huang, William; Hershfield, Michael, Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase.
  664. Peled, Amnon; Begin, Michal; Beider, Katia; Abraham, Michal, Methods for obtaining a therapeutically effective amount of hematopoietic precursor cells and long term engraftment thereof.
  665. Winslow, Robert M.; Vandegriff, Kim D., Methods for oxygen transport comprising a high oxygen affinity modified hemoglobin.
  666. Cicardi, Marco; Bergamaschini, Luigi, Methods for preserving organs and tissues.
  667. Cicardi, Marco; Bergamaschini, Luigi, Methods for preserving organs and tissues.
  668. Cicardi,Marco; Bergamaschini,Luigi, Methods for preserving organs and tissues.
  669. Morin, Paul; Lin, Zheng, Methods for protein refolding.
  670. Talarico,Todd Lewis; Stacey,Cyrus John, Methods for purification of an activated PEG solution and for the synthesis of a modified hemoglobin solution.
  671. Basile, Lena A., Methods for radiation protection by administering IL-12.
  672. Bookbinder, Louis; Kundu, Anirban; Frost, Gregory I., Methods for reducing intraocular pressure by administering a soluble hyaluronidase glycoprotein (sHASEGP).
  673. DeFrees, Shawn; Kinealy, Kyle, Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography.
  674. Stavenhagen, Jeffrey B.; Koenig, Scott, Methods for the treatment of disease using immunoglobulins having Fc Regions with altered affinities for FcγRactivating and FcγRinhibiting .
  675. Stavenhagen, Jeffrey B.; Koenig, Scott, Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRactivating and FcγRinhibiting.
  676. Sehl, Louis C.; Trollsas, Olof Mikael; Wallace, Donald G.; Toman, David; DeLustro, Frank A.; Schroeder, Jacqueline A.; Chu, George H., Methods for tissue repair using adhesive materials.
  677. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP).
  678. Jin, Jian-Ping, Methods for treating cardiac disease by modifying an N-terminal domain of troponin I.
  679. Marchionni, Mark; Kelly, Ralph; Lorell, Beverly; Sawyer, Douglas B., Methods for treating congestive heart failure.
  680. Marchionni, Mark; Kelly, Ralph; Lorell, Beverly; Sawyer, Douglas B., Methods for treating congestive heart failure.
  681. Marchionni, Mark; Kelly, Ralph; Lorell, Beverly; Sawyer, Douglas B., Methods for treating congestive heart failure.
  682. Marchionni, Mark; Kelly, Ralph; Lorell, Beverly; Sawyer, Douglas B., Methods for treating congestive heart failure.
  683. Thomason, Arlen; Liu, Benxian, Methods for treating diabetes using fibroblast growth factor-like polypeptides.
  684. Thomason, Arlen; Liu, Benxian, Methods for treating diabetes using fibroblast growth factor-like polypeptides.
  685. Bookbinder, Louis; Kundu, Anirban; Frost, Gregory I., Methods for treating edema by administering a Soluble Hyaluronidase Glycoprotein (sHASEGP).
  686. Thomason, Arlen; Liu, Benxian, Methods for treating obesity using fibroblast growth factor-like polypeptides.
  687. Thomason, Arlen; Liu, Benxian, Methods for treating obesity using fibroblast growth factor-like polypeptides.
  688. Peters, Kevin; Shalwitz, Robert, Methods for treating vascular leak syndrome and cancer.
  689. Goto,Masaaki; Tsuda,Eisuke; Mochizuki,Shin'ichi; Yano,Kazuki; Kobayashi,Fumie; Shima,Nobuyuki; Yasuda,Hisataka; Nakagawa,Nobuaki; Morinaga,Tomonori; Ueda,Masatsugu; Higashio,Kanji, Methods for using the osteoclastogenesis inhibitory factor (OCIF) protein.
  690. Ekwuribe, Nnochiri N.; Radhakrishnan, Balasingam; Price, Christopher H.; Anderson, Jr., Wes; Ansari, Aslam M., Methods of activating a receptor using amphiphilic drug-oligomer conjugates.
  691. Hsei, Vanessa; Koumenis, Iphigenia; Leong, Steven; Shahrokh, Zahra; Zapata, Gerardo, Methods of binding TNF-α using anti-TNF-α antibody fragment-polymer conjugates.
  692. Migone, Thi-Sau; Klein, Jerry L.; Oki, Yasuhiro; Younes, Anas, Methods of diagnosing and prognosing hodgkin's lymphoma.
  693. Pelleymounter, Mary Ann; Toombs, Christopher Francis; Mann, Michael Benjamin, Methods of increasing lean tissue mass using OB protein compositions.
  694. Pelleymounter,Mary Ann; Toombs,Christopher Francis; Mann,Michael Benjamin, Methods of increasing lean tissue mass using OB protein compositions.
  695. MacDonald, Brian R.; Kaushansky, Kenneth, Methods of increasing platelet and hematopoietic stem cell production.
  696. MacDonald, Brian R.; Kaushansky, Kenneth, Methods of increasing platelet and hematopoietic stem cell production.
  697. Zhao, Hong; Wu, Dechun, Methods of preparing activated polymers having alpha nitrogen groups.
  698. Zhao, Hong; Rubio, Belen; Xia, Jing, Methods of preparing polymers having terminal amine groups.
  699. Zhao, Hong; Rubio, Belen, Methods of preparing polymers having terminal amine groups using protected amine salts.
  700. Zhao, Hong; Rubio, Belen, Methods of preparing polymers having terminal amine groups using protected amine salts.
  701. Cabilly Shmuel ; Heyneker Herbert L. ; Holmes William E. ; Riggs Arthur D. ; Wetzel Ronald B., Methods of producing immunoglobulins, vectors and transformed host cells for use therein.
  702. Rudolph, Alfred R.; Tuthill, Cynthia W., Methods of protecting against radiation damage using alpha thymosin.
  703. Yamaguchi, Kyoji; Yasuda, Hisataka; Nakagawa, Nobuaki; Shima, Nobuyuki; Kinosaki, Masahiko; Tsuda, Eisuke; Goto, Masaaki; Yano, Kazuki; Tomoyasu, Akihiro; Kobayashi, Fumie; Washida, Naohiro; Takahashi, Ken; Morinaga, Tomonori; Higashio, Kanji, Methods of reducing bone absorption comprising administering an antibody that binds OBM.
  704. Still, James Gordon; Kosutic, Gordana, Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus.
  705. Soltero, Richard; Radhakrishnan, Balasingam; Ekwuribe, Nnochiri N., Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same.
  706. Ekwuribe, Nnochiri N.; Price, Christopher H.; Ansari, Aslam M.; Odenbaugh, Amy L., Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties.
  707. Salcedo,Theodora W.; Ruben,Steven M.; Rosen,Craig A.; Albert,Vivian R.; Dobson,Claire; Vaughan,Tristan, Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors.
  708. Salcedo,Theodora W.; Ruben,Steven M.; Rosen,Craig A.; Albert,Vivian R.; Dobson,Claire; Vaughan,Tristan, Methods of treating cancer using antibodies that immunospecifically bind to trail receptors.
  709. Ekwuribe,Nnochiri N.; Price,Christopher H.; Still,James Gordon; Filbey,Jennifer Ann, Methods of treating diabetes mellitus.
  710. , Methods of treating diabetes mellitus.
  711. Prickett, Kathryn S.; Young, Andrew A., Methods of treating diabetes with albumin-conjugated exendin peptides.
  712. Kim,Kyung Jin, Methods of treating diseases with anti-VEGF antibodies.
  713. Scheer, Justin; Ouyang, Wenjun; Vandlen, Richard; Hass, Philip E.; Stefanich, Eric Gary; Wang, Xiaoting, Methods of treating inflammatory bowel disease using IL-22 Fc fusion proteins.
  714. Vanessa Hsei ; Iphigenia Koumenis ; Steven Leong ; Leonard Presta ; Zahra Shahrokh ; Gerardo Zapata, Methods of treating inflammatory disease with anti-IL-8 antibody fragment-polymer conjugates.
  715. Vanessa Hsei ; Iphigenia Koumenis ; Steven Leong ; Leonard Presta ; Zahra Shahrokh ; Gerardo Zapata, Methods of treating inflammatory diseases with anti-IL-8 antibody fragment-polymer conjugates.
  716. Belouski, Edward John; Ellison, Murielle Marie; Hamburger, Agnes Eva; Hecht, Randy Ira; Li, Yue-Sheng; Michaels, Mark Leo; Sun, Jeonghoon; Xu, Jing, Methods of treating of diabetes and obesity using FGF21 mutants.
  717. Chuang, Woei-Jer; Fu, Wen-Mei; Ku, Mannching Sherry; Huang, Yen-Lun, Methods of treating αvβ3 integrin-associated diseases by administering polypeptides selective for αvβ3 integrin.
  718. Puri, Kamal D.; Evarts, Jerry B.; Lannutti, Brian; Giese, Neill, Methods of treatment for solid tumors.
  719. Keller, Gilbert; Frost, Gregory I., Methods of treatment of cellulite.
  720. Keller, Gilbert; Frost, Gregory I., Methods of treatment of collagen-mediated diseases and conditions.
  721. Yu, Guo-Liang; Ebner, Reinhard; Ni, Jian, Methods of treatment using antibodies to Neutrokine-alpha.
  722. Yu, Guo-Liang; Ebner, Reinhard; Ni, Jian, Methods of treatment using antibodies to neutrokine-alpha.
  723. Zopf, David A.; Lubenau, Heinz, Methods of treatment using glycopegylated G-CSF.
  724. Wei,Ying Fei; Ni,Jian; Gentz,Reiner L.; Ruben,Steven M., Methods of treatment with TNFR5.
  725. Opawale, Foyeke; Soltero, Richard, Micro-particle fatty acid salt solid dosage formulations for therapeutic agents.
  726. McNally, Elizabeth; Heydemann, Ahlke; Ceco, Ermelinda, Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (LTBP4).
  727. Basile, Lena A.; Ellefson, Dolph; Gallaher, Timothy K., Mitigation of cutaneous injury with IL-12.
  728. Ekwuribe, Nnochiri N.; Price, Christopher H.; Ansari, Aslam M.; Odenbaugh, Amy L., Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same.
  729. Ekwuribe,Nnochiri N.; Price,Christopher H.; Ansari,Aslam M.; Odenbaugh,Amy L., Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same.
  730. Ekwuribe, Nnochiri N.; Price, Christopher H.; Ansari, Aslam M.; Odenbaugh, Amy L., Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same.
  731. Ekwuribe, Nnochiri N.; Price, Christopher H.; Ansari, Aslam M.; Odenbaugh, Amy L., Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same.
  732. Ekwuribe,Nnochiri N.; Price,Christopher H.; Ansari,Aslam M.; Radhakrishnan,Balasingam; Odenbaugh,Amy L., Mixtures of insulin drug-oligomer comprising polyalkylene glycol.
  733. Ekwuribe, Nnochiri N.; Price, Christopher H.; Ansari, Aslam M.; Radhakrishnan, Balasingam; Odenbaugh, Amy L., Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same.
  734. Ekwuribe,Nnochiri N.; Price,Christopher H.; Ansari,Aslam M.; Radhakrishnan,Balasingam; Odenbaugh,Amy L., Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same.
  735. Cowley, Michael; Cone, Roger; Low, Malcolm; Butler, Andrew; Bloom, Stephen Robert; Small, Caroline Jane; Batterham, Rachel Louise; Ghatei, Mohammad Ali, Modification of feeding behavior.
  736. Cowley,Michael; Cone,Roger; Low,Malcolm; Butler,Andrew; Bloom,Stephen Robert; Small,Caroline Jane; Batterham,Rachel Louise; Ghatel,Mohammad Ali, Modification of feeding behavior.
  737. Cowley, Michael; Cone, Roger; Low, Malcolm James Duncan; Butler, Andrew; Bloom, Stephen Robert; Small, Caroline Jane; Batterham, Rachel Louise; Ghatei, Mohammad Ali, Modification of feeding behavior using PYY and GLP-1.
  738. Bloom, Stephen Robert; Ghatei, Mohammad Ali; Small, Caroline Jane; Dakin, Catherine Louise, Modification of feeding behaviour.
  739. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  740. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  741. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  742. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  743. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  744. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  745. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  746. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  747. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  748. Gegg,Colin; Xiong,Fei; Sitney,Karen C., Modified Fc molecules.
  749. Moore, Stanley; Ghatei, Mohammad; Bloom, Stephen Robert, Modified PYY (3-36) peptides and their effects on feeding behavior.
  750. Wolfman, Neil M.; Khor, Soo Peang; Tomkinson, Kathleen N., Modified and stabilized GDF propeptides and uses thereof.
  751. Wolfman, Neil M.; Khor, Soo-Peang; Tomkinson, Kathleen N., Modified and stabilized GDF propeptides and uses thereof.
  752. Wolfman,Neil M.; Khor,Soo Peang; Tomkinson,Kathleen N., Modified and stabilized GDF propeptides and uses thereof.
  753. Allison, Anthony, Modified annexin compositions and methods of using same.
  754. Allison, Anthony Clifford, Modified annexin compositions and methods of using same.
  755. Allison, Anthony, Modified annexin proteins and methods for preventing thrombosis.
  756. Allison, Anthony, Modified annexin proteins and methods for their use in organ transplantation.
  757. Allison,Anthony, Modified annexin proteins and methods for treating vaso-occlusive sickle-cell disease.
  758. Allison,Anthony, Modified annexin proteins, and methods and compositions for using them.
  759. Hoffmann, Ralf; Berthold, Nicole; Nollmann, Friederike, Modified antibiotic peptides having variable systemic release.
  760. Hoffmann, Ralf; Berthold, Nicole; Nollmann, Friederike, Modified antibiotic peptides having variable systemic release.
  761. Clark Mike A., Modified arginine deiminase.
  762. Clark, Mike A., Modified arginine deiminase.
  763. Prickett, Karthryn S.; Young, Andrew A., Modified exendins and exendin agonists.
  764. Prickett, Kathryn S.; Young, Andrew A., Modified exendins and exendin agonists.
  765. Prickett, Kathryn S.; Young, Andrew A., Modified exendins and exendin agonists.
  766. Inada Yuji (Tokyo JPX), Modified lipase.
  767. Feige,Ulrich, Modified peptides as therapeutic agents.
  768. Arne Agerlin Olsen DK; Claus von der Osten DK; Kim Vilbour Andersen DK; Steffen Ernst DK; Erwin Ludo Roggen DK, Modified polypeptide.
  769. Weisgerber David J. ; Rubingh Donn N., Modified polypeptides with high activity and reduced allergenicity.
  770. Arne Agerlin Olsen DK; Annette Prento DK, Modified protease having 5 to 13 covalently coupled polymeric molecules for skin care.
  771. Clark, Mike A., Modified tumor necrosis factor.
  772. Mathis, Luc; Voytas, Daniel F.; Zhang, Feng; Haun, William, Modifying soybean oil composition through targeted knockout of the FAD2-1A/1B genes.
  773. Bonas, Ulla; Boch, Jens; Schornack, Sebastian; Lahaye, Thomas, Modular DNA-binding domains and methods of use.
  774. Bonas, Ulla; Boch, Jens; Schornack, Sebastian; Lahaye, Thomas, Modular DNA-binding domains and methods of use.
  775. Bonas, Ulla; Boch, Jens; Schornack, Sebastian; Lahaye, Thomas, Modular DNA-binding domains and methods of use.
  776. Bonas, Ulla; Boch, Jens; Schornack, Sebastian; Lahaye, Thomas, Modular DNA-binding domains and methods of use.
  777. Bonas, Ulla; Boch, Jens; Schornack, Sebastian; Lahaye, Thomas, Modular DNA-binding domains and methods of use.
  778. Bonas, Ulla; Boch, Jens; Schornack, Sebastian; Lahaye, Thomas, Modular DNA-binding domains and methods of use.
  779. Bernett, Matthew; Chu, Seung; Wickramarachichi, Dilki; Desjarlais, John, Modulation of T cells with bispecific antibodies and FC fusions.
  780. Hoarty, Michelle Denise; Dhamnaskar, Ketki Ashok; Elbaum, Daniel; Josephson, Kristopher; Larson, Kelley Cronin; Ma, Zhong; Nims, Nathan Ezekiel; Ricardo, Alonso; Seyb, Kathleen; Tang, Guo-Qing; Treco, Douglas A.; Wang, Zhaolin; Ye, Ping; Zheng, Hong; Perlmutter, Sarah Jacqueline; Hammer, Robert Paul, Modulation of complement activity.
  781. Hoarty, Michelle Denise; Dhamnaskar, Ketki Ashok; Elbaum, Daniel; Josephson, Kristopher; Larson, Kelley Cronin; Ma, Zhong; Nims, Nathan Ezekiel; Ricardo, Alonso; Seyb, Kathleen; Tang, Guo-Qing; Treco, Douglas A.; Wang, Zhaolin; Ye, Ping; Zheng, Hong; Perlmutter, Sarah Jacqueline; Hammer, Robert Paul, Modulation of complement activity.
  782. Friedman, Jeffrey M.; Zhang, Yiying; Proenca, Ricardo, Modulators of body weight, corresponding nucleic acids and proteins.
  783. Friedman Jeffrey M. ; Zhang Yiying ; Proenca Ricardo, Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof.
  784. Hoarty, Michelle Denise; Dhamnaskar, Ketki Ashok; Elbaum, Daniel; Josephson, Kristopher; Larson, Kelley Cronin; Ma, Zhong; Nims, Nathan Ezekiel; Ricardo, Alonso; Seyb, Kathleen; Tang, Guo-Qing; Treco, Douglas A.; Wang, Zhaolin; Ye, Ping; Zheng, Hong; Perlmutter, Sarah Jacqueline, Modulators of complement activity.
  785. Bartley Timothy D. ; Bogenberger Jakob M. ; Bosselman Robert A. ; Hunt Pamela ; Kinstler Olaf B. ; Samal Babru B., Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation.
  786. Goto, Masaaki; Tsuda, Eisuke; Mochizuki, Shin'ichi; Yano, Kazuki; Kobayashi, Fumie; Shima, Nobuyuki; Yasuda, Hisataka; Nakagawa, Nobuaki; Morinaga, Tomonori; Ueda, Masatsugu; Higashio, Kanji, Monoclonal antibodies that bind OCIF.
  787. Anderson,Dirk M., Monoclonal blocking antibody to human RANKL.
  788. Harris, J. Milton; Veronese, Francesco Maria; Caliceti, Paola; Schiavon, Oddone, Multi-armed, monofunctional, and hydrolytically stable derivatives of poly (ethylene glycol) and related polymers for modification of surfaces and molecules.
  789. Harris, J. Milton; Veronese, Francesco M.; Caliceti, Paolo; Schiavon, Oddone, Multi-armed, monofunctional, and hydrolytically stable derivatives of poly(ethylene glycol) and related polymers for modification of surfaces and molecules.
  790. Harris, J. Milton; Veronese, Francesco Maria; Caliceti, Paolo; Schiavon, Oddone, Multi-armed, monofunctional, and hydrolytically stable derivatives of poly(ethylene glycol) and related polymers for modification of surfaces and molecules.
  791. Harris J. Milton ; Veronese Francesco Maria,ITX ; Caliceti Paolo,ITX ; Schiavon Oddone,ITX, Multiarmed, monofunctional, polymer for coupling to molecules and surfaces.
  792. Dixit, Surjit Bhimarao; D'Angelo, Igor Edmondo Paolo; Poon, David Kai Yuen, Multivalent heteromultimer scaffold design and constructs.
  793. Dixit, Surjit Bhimarao; D'Angelo, Igor Edmondo Paolo; Sanches, Mario; Ng, Gordon Yiu Kon, Multivalent heteromultimer scaffold design and constructs.
  794. Dixit, Surjit Bhimarao; D'Angelo, Igor Edmundo Paolo; Poon, David Kai Yuen, Multivalent heteromultimer scaffold design and constructs.
  795. Jones, David S., Multivalent platform molecules comprising high molecular weight polyethylene oxide.
  796. Blattmann, Beat O; Darzins, Aldis; Davis, John M.; Encell, Lance P.; Morrison, Thomas B.; Mrachko, Gregory T.; Schellenberger, Volker, Mutant .
  797. Donnelly, Mark; Eschenfeldt, William H.; Trent, Jonathan, Mutant 2,5-diketo-L-gluconic acid reductases.
  798. Donnelly,Mark; Eschenfeldt,William H.; Trent,Jonathan, Mutant 2.5-diketo-L-gluconic acid reductases.
  799. Jeanplong, Ferenc; McMahon, Christopher David, Myostatin isoform.
  800. Shen, Xiaoming, N-maleimidyl polymer derivatives.
  801. Shen, Xiaoming, N-maleimidyl polymer derivatives.
  802. Shen, Xiaoming, N-maleimidyl polymer derivatives.
  803. Shen, Xiaoming, N-maleimidyl polymer derivatives.
  804. Shen, Xiaoming, N-maleimidyl polymer derivatives.
  805. Shen, Xiaoming, N-maleimidyl polymer derivatives.
  806. Shen, Xiaoming, N-maleimidyl polymer derivatives.
  807. Shen, Xiaoming, N-maleimidyl polymer derivatives.
  808. Gabriel,Nancy E.; Farrar,Christine E., N-terminally chemically modified protein compositions and methods.
  809. Kinstler Olaf B. ; Gabriel Nancy E. ; Farrar Christine E. ; DePrince Randolph B., N-terminally chemically modified protein compositions and methods.
  810. Kinstler, Olaf B., N-terminally chemically modified protein compositions and methods.
  811. Kinstler, Olaf B.; Gabriel, Nancy Elise; Farrar, Christine E.; DePrince, Randolph B., N-terminally chemically modified protein compositions and methods.
  812. Kinstler, Olaf B.; Gabriel, Nancy Elise; Farrar, Christine E.; DePrince, Randolph B., N-terminally chemically modified protein compositions and methods.
  813. Mirkin, Chad A.; Ko, Caroline H.; Stegh, Alexander; Giljohann, David A.; Luciano, Janina; Jensen, Samuel A., Nanoconjugates able to cross the blood-brain barrier.
  814. James, Kenneth D.; Radhakrishnan, Balasingam; Malkar, Navdeep B.; Miller, Mark A.; Ekwuribe, Nnochiri N., Natriuretic compounds, conjugates, and uses thereof.
  815. Zhou, Mingdong, Neuregulin based methods and compositions for treating cardiovascular disease.
  816. Zhou, Mingdong, Neuregulin based methods and compositions for treating cardiovascular diseases.
  817. Zhou, Mingdong, Neuregulin based methods and compositions for treating cardiovascular diseases.
  818. Zhou, Mingdong, Neuregulin variants and methods of screening and using thereof.
  819. Zhou, Mingdong, Neuregulin variants and methods of screening and using thereof.
  820. Zhou, Mingdong, Neuregulin variants and methods of screening and using thereof.
  821. Lanzavecchia, Antonio, Neutralizing anti-influenza A virus antibodies and uses thereof.
  822. Lanzavecchia, Antonio, Neutralizing anti-influenza A virus antibodies and uses thereof.
  823. Lanzavecchia, Antonio, Neutralizing anti-influenza A virus antibodies and uses thereof.
  824. Lanzavecchia, Antonio, Neutralizing anti-influenza A virus antibodies and uses thereof.
  825. Yu, Guo-Liang; Ebner, Reinhard; Ni, Jian, Neutrokine-alpha antibodies and methods of use thereof.
  826. Yu, Guo-Liang; Ebner, Reinhard; Ni, Jian, Neutrokine-alpha fusion proteins.
  827. Holmes, Christopher P.; Chakrabarti, Anjan; Frederick, Brian T.; Pan, Yijun; Dong, Yaohua S.; Bhandari, Ashok, Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules.
  828. Greenwald Richard B. ; Martinez Anthony ; Pendri Annapurna, Non-antigenic amine derived polymers and polymer conjugates.
  829. Greenwald Richard B. ; Martinez Anthony ; Pendri Annapurna, Non-antigenic amine derived polymers and polymer conjugates.
  830. Greenwald Richard B. ; Martinez Anthony ; Pendri Annapurna, Non-antigenic amine derived polymers and polymer conjugates.
  831. Greenwald Richard B. ; Martinez Anthony J., Non-antigenic branched polymer conjugates.
  832. Greenwald, Richard B.; Martinez, Anthony J., Non-antigenic branched polymer conjugates.
  833. Segev, David, Nucleic acid derivatives.
  834. Segev,David, Nucleic acid derivatives.
  835. Segev,David, Nucleic acid derivatives.
  836. Mirkin, Chad A.; Giljohann, David A.; Seferos, Dwight, Nucleic acid functionalized nanoparticles for therapeutic applications.
  837. Mirkin, Chad A.; Rosi, Nathaniel L.; Thaxton, C. Shad; Giljohann, David A., Nucleic acid functionalized nanoparticles for therapeutic applications.
  838. Mirkin, Chad A.; Rosi, Nathaniel L.; Thaxton, C. Shad; Giljohann, David A., Nucleic acid functionalized nanoparticles for therapeutic applications.
  839. Mirkin, Chad A.; Rosi, Nathaniel L.; Thaxton, C. Shad; Giljohann, David A., Nucleic acid functionalized nonoparticles for therapeutic applications.
  840. Brown, Larry R.; Gillis, Kimberly A.; Gallo, Michael V., Nucleic acid microparticles for pulmonary delivery.
  841. Madison,Edwin L.; Yeh,Jiunn Chern, Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon.
  842. Madison,Edwin L.; Ong,Edgar O., Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon.
  843. Madison,Edwin L.; Ong,Edgar O., Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon.
  844. Thomason, Arlen; Liu, Benxian, Nucleic acid molecules encoding fibroblast growth factor-like polypeptides.
  845. Goto,Masaaki; Tsuda,Eisuke; Mochizuki,Shin'ichi; Yano,Kazuki; Kobayashi,Fumie; Shima,Nobuyuki; Yasuda,Hisataka; Nakagawa,Nobuaki; Morinaga,Tomonori; Ueda,Masatsugu; Higashio,Kanji, Nucleic acid molecules encoding osteoclastogenesis inhibitory factor proteins.
  846. Madison,Edwin L.; Yeh,Jiunn Chern, Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereon.
  847. Madison, Edwin L.; Ong, Edgar O.; Yeh, Jiunn-Chern, Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon.
  848. Madison, Edwin L.; Ong, Edgar O.; Yeh, Jiunn-Chern, Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon.
  849. Friedman Jeffrey M. ; Zhang Yiying ; Proenca Ricardo ; Maffei Margherita, Nucleic acid primers and probes for the mammalian OB gene.
  850. Oeth, Paul Andrew; Mahboubi, Payam; Lee, Min Seob, Nucleic acid-based tests for prenatal gender determination.
  851. Valge-Archer, Viia; Williams, Andrew James; Young, Deborah A.; Whitters, Matthew J.; Collins, Mary; Witek, Joann, Nucleic acids coding for antibodies against human IL-21 receptor and uses therefor.
  852. Scheer, Justin; Ouyang, Wenjun; Vandlen, Richard; Hass, Philip E.; Stefanich, Eric Gary; Wang, Xiaoting, Nucleic acids encoding IL-22 Fc fusion proteins.
  853. Brewer, Michael T.; Thompson, Robert C.; Kohno, Tadahiko, Nucleic acids encoding TNF inhibitor and method of production.
  854. Baciu, Peter C.; Liang, Yanbin; Guu, Jason; Bernett, Matthew; Muchhal, Umesh; Desjarlais, John, Nucleic acids encoding complement component C5 antibodies.
  855. Madison,Edwin L.; Ong,Edgar O., Nucleic acids encoding endotheliases, endotheliases and uses thereof.
  856. Friedman, Jeffrey M.; Zhang, Yiying; Proenca, Ricardo; Maffei, Margherita; Halaas, Jeffrey L.; Gajiwala, Ketan; Burley, Stephen K., Nucleic acids encoding modulators of body weight.
  857. Fisher, Eric; Edwards, III, Carl; Kieft, Gary, Nucleic acids encoding truncated soluble tumor necrosis factor.
  858. Haider, Stefan; Ivens, Andreas; Rottensteiner, Hanspeter; Siekmann, Juergen; Turecek, Peter, Nucleophilic catalysts for oxime linkage.
  859. Siekmann, Juergen; Haider, Stefan; Rottensteiner, Hanspeter; Ivens, Andreas; Turecek, Peter; Zoechling, Oliver, Nucleophilic catalysts for oxime linkage.
  860. Siekmann, Juergen; Haider, Stefan; Rottensteiner, Hanspeter; Turecek, Peter, Nucleophilic catalysts for oxime linkage.
  861. Siekmann, Juergen; Haider, Stefan; Rottensteiner, Hanspeter; Turecek, Peter, Nucleophilic catalysts for oxime linkage.
  862. Felo, Michael; DeFrees, Shawn, Nucleotide sugar purification using membranes.
  863. Wang Yang ; Spellman Michael W., O-fucosyltransferase.
  864. DeFrees, Shawn; Zopf, David A.; Wang, Zhi-Guang; Clausen, Henrik, O-linked glycosylation of peptides.
  865. Mann, Michael B.; Hecht, Randy Ira; Pelleymounter, Mary Ann; Toombs, Christopher Francis, OB fusion protein compositions and methods.
  866. Mann,Michael B.; Hecht,Randy Ira; Pelleymounter,Mary Ann; Toombs,Christopher Francis, OB fusion protein compositions and methods.
  867. Friedman Jeffrey M. ; Zhang Yiying ; Proenca Ricardo, OB polypeptide antibodies and method of making.
  868. Jeffrey M. Friedman ; Yiying Zhang ; Ricardo Proenca, OB polypeptides and modified forms as modulators of body weight.
  869. Friedman Jeffrey M. ; Zhang Yiying ; Proenca Ricardo, OB polypeptides as modulators of body weight.
  870. Friedman Jeffrey M. ; Zhang Yiying ; Proenca Ricardo, OB polypeptides, modified forms and compositions.
  871. Friedman, Jeffrey M.; Halaas, Jeffrey L.; Gajiwala, Ketan; Burley, Stephen K., OB polypeptides, modified forms and derivatives.
  872. Pelleymounter, Mary Ann; Hecht, Randy Ira; Mann, Michael Benjamin, OB protein compositions and methods.
  873. Jeffrey M. Friedman ; Yiying Zhang ; Ricardo Proenca, Ob polypeptides, modified forms and compositions thereto.
  874. DeFrees, Shawn; Zopf, David A.; Taudte, Susann; Willett, Walter Scott; Bayer, Robert J.; Kalo, Matthew, One pot desialylation and glycopegylation of therapeutic peptides.
  875. Moore, Gregory; Bernett, Matthew; Rashid, Rumana; Desjarlais, John, Optimized antibody variable regions.
  876. Barbosa, Maria D.; Chamberlain, Aaron K.; Desjarlais, John R., Optimized proteins that target Ep-CAM.
  877. Khedkar, Anand; Rangappa, Sharath Kumar Mallapura; Subramani, Ramesh; Dave, Nitesh; Radhakrishnan, Devesh; Shankar, Sundaresh; Chivukula, Sudheer; Ramakrishna, Ranjith; Murthy, Shanmugam Thandava; Pai, Harish Venkatraman; Sengupta, Nilanjan; Melarkode, Ramakrishnan; Iyer, Harish, Orally administrable solid pharmaceutical composition and a process thereof.
  878. Magruder Judy A. ; Eckenhoff James B. ; Cortese Richard ; Wright Jeremy C. ; Peery John R. ; Pike James B. ; Robinson Urano A. ; Smith Jonathan P. ; Ziemann Lyle E., Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals.
  879. Boyle William J. ; Lacey David L. ; Calzone Frank J. ; Chang Ming-Shi, Osteoprotegerin.
  880. Boyle William J. ; Lacey David L. ; Calzone Frank J. ; Chang Ming-Shi, Osteoprotegerin.
  881. Boyle William J. ; Lacey David L. ; Calzone Frank J. ; Chang Ming-Shi, Osteoprotegerin.
  882. Boyle William J. ; Lacey David L. ; Calzone Frank J. ; Chang Ming-Shi, Osteoprotegerin.
  883. Boyle, William J.; Lacey, David L.; Calzone, Frank J.; Chang, Ming Shi, Osteoprotegerin.
  884. Boyle, William J.; Lacey, David L.; Calzone, Frank J.; Chang, Ming-Shi, Osteoprotegerin.
  885. William J. Boyle ; David L. Lacey ; Frank J. Calzone ; Ming-Shi Chang, Osteoprotegerin.
  886. Boyle,William J., Osteoprotegerin binding proteins.
  887. Nakamura, Teruo; Sekimori, Yasuo; Machida, Minoru; Kawata, Hiromitsu; Miyamoto, Hajime, PEG-conjugated erythropoietin.
  888. Ensor, Charles Mark; Clark, Mike A.; Holtsberg, Frederick Wayne, PEG-modified uricase.
  889. Williams, L. David; Hershfield, Michael S.; Kelly, Susan J.; Saifer, Mark G. P.; Sherman, Merry R., PEG-urate oxidase conjugates and use thereof.
  890. Williams, L. David; Hershfield, Michael S.; Kelly, Susan J.; Saifer, Mark G. P.; Sherman, Merry R., PEG-urate oxidase conjugates and use thereof.
  891. Williams, L. David; Hershfield, Michael S.; Kelly, Susan J.; Saifer, Mark G. P.; Sherman, Merry R., PEG-urate oxidase conjugates and use thereof.
  892. Williams, L. David; Hershfield, Michael S.; Kelly, Susan J.; Saifer, Mark G. P.; Sherman, Merry R., PEG-urate oxidase conjugates and use thereof.
  893. Williams, L. David; Hershfield, Michael S.; Kelly, Susan J.; Saifer, Mark G. P.; Sherman, Merry R., PEG-urate oxidase conjugates and use thereof.
  894. Beals, John Michael; Cutler, Jr., Gordon Butler; Hansen, Ryan John; Li, Shun; Zhang, Lianshan, PEGylated insulin lispro compounds.
  895. Madsen, Peter; Kjeldsen, Thomas Børglum; Tagmose, Tina Møller; Jakobsen, Palle, PEGylated, extended insulins.
  896. Thompson, Robert C.; Brewer, Michael T.; Kohno, Tadahiko, PEGylation reagents and compounds formed therewith.
  897. Wei, Ge; Shepard, H. Michael; Zhao, Qiping; Connor, Robert James, PH20 polypeptide variants, formulations and uses thereof.
  898. Damiano, Jason; Luqman, Mohammad; Bedinger, Daniel; Masat, Linda; Mirza, Amer; Nonet, Genevieve, PRLR-specific antibody and uses thereof.
  899. Mirkin, Chad A.; Seferos, Dwight S.; Giljohann, David A., Particles for detecting intracellular targets.
  900. Mirkin, Chad A.; Seferos, Dwight; Giljohann, David A., Particles for detecting intracellular targets.
  901. Park Joonsup ; Quintana Ronald P. ; Hong Bor-shyue ; Asgharian Bahram, Peg-modified proteases and methods of use in contact lens cleaning.
  902. Brown-Augsburger, Patricia Lea; Kohn, Wayne David, Pegylated PTH as PTH receptor modulators and uses thereof.
  903. Klausen, Niels Kristian; Bjorn, Soren; Behrens, Carsten; Garibay, Patrick William, Pegylated factor VII glycoforms.
  904. Siekmann, Juergen; Varadi, Katalin; Gritsch, Herbert; Turecek, Peter, Pegylated factor VIII.
  905. Siekmann, Juergen; Varadi, Katalin; Gritsch, Herbert; Turecek, Peter, Pegylated factor VIII.
  906. Bailon Pascal Sebastian ; Campfield Arthur ; Devos Rene,BEX ; Guisez Yves,BEX, Pegylated obese (ob) protein compositions.
  907. Wang, Zhaolin; Ye, Ping; Ricardo, Alonso; Josephson, Kristopher; Anderson, Paul; Arata, Michelle Denise; Ma, Zhong; Nims, Nathan Ezekiel; Schneider, Eberhard; Schurmann, Gregor; Wagner, Peter; Treco, Douglas A.; Zheng, Hong; Elbaum, Daniel; Boyer, Nicolas Cedric, Peptide and peptidomimetic inhibitors.
  908. Wang, Zhaolin; Ye, Ping; Ricardo, Alonso; Josephson, Kristopher; Anderson, Paul; Arata, Michelle Denise; Ma, Zhong; Nims, Nathan Ezekiel; Schneider, Eberhard; Schurmann, Gregor; Wagner, Peter; Treco, Douglas A.; Zheng, Hong; Elbaum, Daniel; Boyer, Nicolas Cedric, Peptide and peptidomimetic inhibitors.
  909. Wang, Zhaolin; Ye, Ping; Ricardo, Alonso; Josephson, Kristopher; Anderson, Paul; Hoarty, Michelle Denise; Ma, Zhong; Nims, Nathan Ezekiel; Schneider, Eberhard; Schurmann, Gregor; Wagner, Peter; Treco, Douglas A.; Zheng, Hong; Elbaum, Daniel; Boyer, Nicolas Cedric, Peptide and peptidomimetic inhibitors.
  910. Huang, Jung San, Peptide antagonists of TGF-beta family members and therapeutic uses thereof.
  911. Soares, Christopher J., Peptide antagonists of the calcitonin CGRP family of peptide hormones and their use.
  912. Balu, Palani, Peptide dimers as agonists of the erythropoientin (EPO) receptor, and associated methods of synthesis and use.
  913. Balu,Palani, Peptide dimers as agonists of the erythropoietin (EPO) receptor, and associated methods of synthesis and use.
  914. Newgard, Christopher B.; Stephens, Samuel B.; Schisler, Jonathan C., Peptide therapy for hyperglycemia.
  915. Abraham, Michal; Peled, Amnon; Eizenberg, Orly, Peptide therapy for increasing platelet levels.
  916. Bloom, Stephen Robert, Peptide tyrosine tyrosine analogues.
  917. Wu, Han-Chung; Lin, Chin-Tarng; Lee, Tong-Young; Kuo, Szu-Yao, Peptide-conjugates that bind to VEGF-stimulated or tumor vasculature and methods of treatment.
  918. Dower, William J.; Barrett, Ronald W.; Cwirla, Steven E.; Duffin, David J.; Gates, Christian M.; Haselden, Sherril S.; Mattheakis, Larry C.; Schatz, Peter J.; Wagstrom, Christopher R.; Wrighton, Nicholas C., Peptides and compounds that bind to a receptor.
  919. Balu,Palani; Yin,Qun; England,Bruce, Peptides and compounds that bind to the IL-5 receptor.
  920. Balu,Palani; Yin,Qun; England,Bruce, Peptides and compounds that bind to the IL-5 receptor.
  921. Peled, Amnon; Wald, Ori, Peptides and use thereof in the treatment of large cell lung cancer.
  922. Chung, Yong-Ji; Kim, Young Deug; Kim, Eun Mi; Choi, Jun Young; Song, Sang Su, Peptides having activities of epidermal growth factor and its uses.
  923. Wu, Han-Chung; Lin, Chin-Tarng; Lo, Albert, Peptides specific for hepatocellular carcinoma cells and applications thereof.
  924. Holmes, Christopher P.; Yin, Qun; Lalonde, Guy; Schatz, Peter J.; Tumelty, David; Balu, Palani; Zemede, Genet, Peptides that bind to the erythropoietin receptor.
  925. Holmes, Christopher P.; Yin, Qun; Lalonde, Guy; Schatz, Peter J.; Tumelty, David; Balu, Palani; Zemede, Genet, Peptides that bind to the erythropoietin receptor.
  926. Holmes, Christopher P.; Yin, Qun; Lalonde, Guy; Schatz, Peter J.; Tumelty, David; Palani, Balu; Zemede, Genet, Peptides that bind to the erythropoietin receptor.
  927. Holmes, Christopher P.; Yin, Qun; Lalonde, Guy; Schatz, Peter J.; Tumelty, David; Palani, Balu; Zemede, Genet, Peptides that bind to the erythropoietin receptor.
  928. Holmes,Christopher P.; Yin,Qun; Lalonde,Guy; Schatz,Peter J.; Tumelty,David; Palani,Balu; Zemede,Genet, Peptides that bind to the erythropoietin receptor.
  929. Holmes,Christopher P.; Yin,Qun; Lalonde,Guy; Schatz,Peter J.; Tumelty,David; Palani,Balu; Zemede,Genet, Peptides that bind to the erythropoietin receptor.
  930. Mezo, Adam R.; McDonnell, Kevin A.; Hehir, Cristina A. Tan; Castro, Alfredo, Peptides that block the binding of IgG to FcRn.
  931. Mezo, Adam R.; McDonnell, Kevin A.; Hehir, Cristina A. Tan; Castro, Alfredo, Peptides that block the binding of IgG to FcRn.
  932. Turkson, James; Jove, Richard; Sebti, Said M.; Hamilton, Andrew D., Peptidomimetic inhibitors of STAT activity and uses thereof.
  933. Turkson,James; Jove,Richard; Sebti,Said M.; Hamilton,Andrew D., Peptidomimetic inhibitors of STAT activity and uses thereof.
  934. Rudnicki, Michael; Smid, Johnathan, Periostin-induced pancreatic regeneration.
  935. David John Weisgerber ; Andrew Campbell Allcock, Personal care compositions containing active proteins tethered to a water insoluble substrate.
  936. Weisgerber David John ; Allcock Andrew Campbell, Personal care compositions containing subtilisin enzymes bound to water insoluble substrates.
  937. Soltero, Richard; Ekwuribe, Nnochiri N.; Opawale, Foyeke; Rehlaender, Bruce; Hickey, Anthony; Bovet, Li Li, Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith.
  938. Harris, J. Milton; Kozlowski, Antoni; McManus, Samuel P.; Bentley, Michael D.; Charles, Stephen A., Pharmaceutical compositions of conjugates formed from polymer derivatives having particular atom arrangements.
  939. Soltero,Richard; Ekwuribe,Nnochiri N.; Opawale,Foyeke; Rehlaender,Bruce; Hickey,Anthony; Bovet,Li Li, Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith.
  940. DeFrees,Shawn; Zopf,David A.; Bayer,Robert J.; Bowe,Caryn; Hakes,David James; Chen,Xi, Pharmaceutical compositions of glycoconjugates.
  941. Soltero, Richard; Radhakrishan, Balasingam; Ekwuribe, Nnochiri N.; Rehlaender, Bruce; Hickey, Anthony; Bovet, Li Li, Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith.
  942. Soltero,Richard; Radhakrishan,Balasingam; Ekwuribe,Nnochiri N.; Rehlaender,Bruce; Hickey,Anthony; Bovet,Li Li, Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith.
  943. Shaked Ze\ev (Berkeley CA) Stewart Tracy (San Francisco CA) Thomson James W. (Albany CA) Hirtzer Pamela (Oakland CA), Pharmaceutical compositions of recombinant interleukin-2 and formulation processes.
  944. Cottingham, Ian; Plaksin, Daniel; Aharanov, Jenny, Pharmaceutical preparation.
  945. Orlando, Michele; Hemberger, Jurgen; Delbos Krampe, Jeanne, Pharmaceutically active oligosaccharide conjugates.
  946. Belmont, John W.; Fletcher, Frederick A.; Chen, Alice J.; Jurecic, Roland; Tan, Tse-Hua; Zhou, Guisheng, Phosphatases which activate map kinase pathways.
  947. Belmont,John W.; Fletcher,Frederick A.; Chen,Alice J.; Jurecic,Roland; Tan,Tse Hua; Zhou,Guisheng, Phosphatases which activate map kinase pathways.
  948. Nagaoka Shoji (Kamakura JPX) Kurumatani Hajimu (Kamakura JPX) Mori Yuichi (Kamakura JPX), Physiologically-active substance fixed to a thin fiber carrier with an alkylene oxide chain.
  949. Bertozzi, Carolyn; Agarwal, Paresh; Sletten, Ellen M., Pictet-Spengler ligation for protein chemical modification.
  950. Hunter Robert L. (Tucker GA), Plasma extender.
  951. Sexton, Daniel J.; Viswanathan, Malini, Plasma kallikrein binding proteins.
  952. Sexton, Daniel J.; Viswanathan, Malini, Plasma kallikrein binding proteins.
  953. Shimizu Kimihiro (Yoshikawa JPX) Nakahara Tsuguji (Tokyo JPX) Kinoshita Taketoshi (Koshigaya JPX) Takatsuka Jun (Kawasaki JPX) Igarashi Michiko (Musashino JPX), Plasminogen activator derivatives.
  954. Shimizu Kimihiro (Yoshikawa-danchi 4-16-102 Yoshikawa-machi ; Kitakatsushika-gun ; Saitama-ken JPX) Nakahara Tsuguji (6-21-6 Megurohonmachi ; Meguro-ku ; Tokyo JPX) Kinoshita Taketoshi (Satsuki-so ; , Plasminogen activator derivatives.
  955. Fischetti, Vincent A.; Cheng, Qi, Ply-GBS mutant lysins.
  956. Harris, J. Milton; Kozlowski, Antoni, Poly (ethylene glycol) derivatives with proximal reactive groups.
  957. Harris, J. Milton; Kozlowski, Antoni, Poly (ethylene glycol) derivatives with proximal reactive groups.
  958. Bentley Michael D. ; Harris J. Milton, Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines.
  959. Harris, J. Milton; Kozlowski, Antoni, Poly(ethylene glycol) derivatives with proximal reactive groups.
  960. Harris, J. Milton; Kozlowski, Antoni, Poly(ethylene glycol) derivatives with proximal reactive groups.
  961. J. Milton Harris ; Antoni Kozlowski, Poly(ethylene glycol) derivatives with proximal reactive groups.
  962. J. Milton Harris ; Antoni Kozlowski, Poly(ethylene glycol) derivatives with proximal reactive groups.
  963. Whitlow, Marc; Shorr, Robert G. L.; Filpula, David R.; Lee, Lihsyng Standford, Polyalkylene oxide-modified single chain polypeptides.
  964. Whitlow, Marc; Shorr, Robert G. L.; Filpula, David R.; Lee, Lihsyng Standford, Polyalkylene oxide-modified single chain polypeptides.
  965. Whitlow, Marc; Shorr, Robert G. L.; Filpula, David R.; Lee, Lihsyng Stanford, Polyalkylene oxide-modified single chain polypeptides.
  966. Whitlow,Marc; Shorr,Robert G. L.; Filpula,David R.; Lee,Lihsyng Standford, Polyalkylene oxide-modified single chain polypeptides.
  967. Zhao, Hong, Polyalkylene oxides having hindered ester-based biodegradable linkers.
  968. Lin, KoChung; Pepinsky, R. Blake; Chen, Ling Ling; Hess, Donna M.; Lin, Edward Y.; Petter, Russell C.; Baker, Darren P., Polyalkylene polymer compounds and uses thereof.
  969. Lin, KoChung; Pepinsky, R. Blake; Chen, Ling Ling; Hess, Donna M.; Lin, Edward Y.; Petter, Russell C.; Baker, Darren P., Polyalkylene polymer compounds and uses thereof.
  970. Rose, Keith, Polyamide chains of precise length.
  971. Harris,J. Milton; Kozlowski,Antoni, Polyethylene (glycol) derivatives with proximal reactive groups.
  972. Harris,J. Milton; Kozlowski,Antoni, Polyethylene(Glycol) derivatives with proximal reactive groups.
  973. Hakimi John ; Kilian Patricia ; Rosen Perry, Polyethylene-protein conjugates.
  974. Hakimi John ; Kilian Patricia ; Rosen Perry, Polyethylene-protein conjugates.
  975. Hakimi John ; Kilian Patricia ; Rosen Perry, Polyethylene-protein conjugates.
  976. Hakimi John ; Kilian Patricia ; Rosen Perry, Polyethylene-protein conjugates.
  977. Hakini John (Scarsdale NY) Kilian Patricia (Upper Montclair NJ) Rosen Perry (North Caldwell NJ), Polyethylene-protein conjugates.
  978. Bossard, Mary J.; Bentley, Michael D.; Zhang, Ping, Polymer Factor VIII moiety conjugates.
  979. Pepinsky, Blake; Runkel, Laura; Brickelmaier, Margot; Whitty, Adrian; Hochman, Paula, Polymer conjugates of interferon beta-1A and uses.
  980. Pepinsky,Blake; Runkel,Laura; Brickelmaier,Margot; Whitty,Adrian; Hochman,Paula, Polymer conjugates of interferon beta-1A and uses.
  981. Pepinsky, Blake; Runkel, Laura; Brickelmaier, Margot; Whitty, Adrian; Hochman, Paula, Polymer conjugates of interferon beta-1a and uses.
  982. Saifer, Mark G. P.; Martinez, Alexa L.; Williams, L. David; Sherman, Merry R., Polymer conjugates of interferon-beta with enhanced biological potency.
  983. Sherman,Merry R.; Martinez,Alexa L.; Bhaskaran,Shyam S.; Williams,L. David; Saifer,Mark G. P.; French,John A., Polymer conjugates of proteinases.
  984. Martinez, Alexa L; Sherman, Merry R; Saifer, Mark G. P.; Williams, L. David, Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof.
  985. Harris, J. Milton; Kozlowski, Antoni; McManus, Samuel P.; Bentley, Michael D.; Charles, Stephen A., Polymer derivatives having particular atom arrangements.
  986. Harris, J. Milton; Kozlowski, Antoni, Polymer derivatives with proximal reactive groups.
  987. Bossard, Mary J.; Stephenson Phillips, Gayle, Polymer factor IX moiety conjugates.
  988. Bossard, Mary J.; Bentley, Michael D.; Zhang, Ping, Polymer factor VIII moiety conjugates.
  989. Bentley, Michael David; Roberts, Michael James, Polymer stabilized neuropeptides.
  990. Bentley, Michael David; Roberts, Michael James, Polymer stabilized neuropeptides.
  991. Scheiflinger, Friedrich; Turecek, Peter; Siekmann, Jueren, Polymer von Willebrand factor-conjugates.
  992. Bossard, Mary J.; Stephenson, Gayle, Polymer-factor IX moiety conjugates.
  993. Bossard, Mary J.; Bentley, Michael D.; Zhang, Ping, Polymer-factor VIII conjugate compositions.
  994. Bossard, Mary J.; Bentley, Michael D.; Zhang, Ping, Polymer-factor VIII moiety conjugates.
  995. Bossard, Mary J.; Bentley, Michael D.; Zhang, Ping, Polymer-factor VIII moiety conjugates.
  996. Bossard, Mary J.; Bentley, Michael D.; Zhang, Ping, Polymer-factor VIII moiety conjugates.
  997. Bossard, Mary J.; Bentley, Michael D.; Zhang, Ping, Polymer-factor VIII moiety conjugates.
  998. Bossard,Mary J.; Bentley,Michael D., Polymer-factor VIII moiety conjugates.
  999. Scheiflinger, Friedrich; Turecek, Peter; Siekmann, Juergen, Polymer-factor VIII-von Willebrand factor-conjugates.
  1000. Kochendoerfer,Gerd G.; Botti,Paolo; Bradburne,James A.; Chen,Shiah yun; Cressman,Sonya; Hunter,Christie L.; Kent,Stephen B. H.; Low,Donald W.; Wilken,Jill G., Polymer-modified synthetic proteins.
  1001. Scheiflinger, Friedrich; Turecek, Peter; Siekmann, Juergen, Polymer-von Willebrand factor-conjugates.
  1002. Scheiflinger, Friedrich; Turecek, Peter; Siekmann, Juergen, Polymer-von Willebrand factor-conjugates.
  1003. Greenwald Richard B. ; Pendri Annapurna ; Choe Yun H., Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents.
  1004. Veronese Francesco M. (Padua ITX) Schiavon Oddone (Padua ITX) Caliceti Paolo (Padua ITX) Sartore Luciana (Marano Vic. ITX) Ranucci Elisabetta (Brescia ITX) Ferruti Paolo (Milan ITX), Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces.
  1005. Veronese Francesco M. (Padua ITX) Schiavon Oddone (Padua ITX) Caliceti Paolo (Padua ITX) Sartore Luciana (Marano Vic. ITX) Ranucci Elisabetta (Brescia ITX) Ferruti Paolo (Milan ITX), Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces.
  1006. Carra, Ernest; Gerber, Michael; Shi, Bing; Sujino, Keiko; Tran, Duong; Wang, Fang; Evarts, Jerry B., Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one.
  1007. Carra, Ernest; Gerber, Michael; Shi, Bing; Sujino, Keiko; Tran, Duong; Wang, Fang; Evarts, Jerry B., Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one.
  1008. Buttar, Suzanne; Carra, Ernest; Ehiwe, Tracy; Tran, Duong; Wang, Fang; Worrall, Christopher; Evarts, Jerry, Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one.
  1009. Feder,John N.; Nelson,Thomas C.; Chen,Jian; Meegalla,Rupalie; Ramaker,Michael; Cheng,Dong, Polynucleotide encoding a novel acyl coenzyme A, monoacylglycerol acyltransferase-3 (MGAT3), and uses thereof.
  1010. Emanuele R. Martin (Alpharetta GA) Hunter Robert L. (Tucker GA) Culbreth Paula H. (Loganville GA), Polyoxypropylene/polyoxyethylene copolmers with improved biological activity.
  1011. Emanuele R. Martin ; Hunter Robert L. ; Culbreth Paula H., Polyoxypropylene/polyoxyethylene copolmers with improved biological activity.
  1012. Emanuele R. Martin ; Hunter Robert L. ; Culbreth Paula H., Polyoxypropylene/polyoxyethylene copolymers with improved biological activity.
  1013. Emanuele R. Martin ; Hunter Robert L. ; Culbreth Paula H., Polyoxypropylene/polyoxyethylene copolymers with improved biological activity.
  1014. Emanuele, R. Martin; Hunter, Robert L.; Culbreth, Paula H., Polyoxypropylene/polyoxyethylene copolymers with improved biological activity.
  1015. Emanuele, R. Martin; Hunter, Robert L.; Culbreth, Paula H., Polyoxypropylene/polyoxyethylene copolymers with improved biological activity.
  1016. R. Martin Emanuele ; Robert L. Hunter ; Paula H. Culbreth, Polyoxypropylene/polyoxyethylene copolymers with improved biological activity.
  1017. Fujii, Nobutaka, Polypeptide anti-HIV agent containing the same.
  1018. Olsen Arne Agerlin,DKX ; Hansen Lars Bo,DKX ; Beck Thomas Christian,DKX, Polypeptide with reduced allergenicity.
  1019. Olsen Arne Agerlin,DKX ; Hansen Lars Bo,DKX ; Beck Thomas Christian,DKX, Polypeptide with reduced allergenicity.
  1020. Olsen Arne Agerlin,DKX ; Hansen Lars Bo,DKX ; Beck Thomas Christian,DKX, Polypeptide with reduced respiratory allergenicity.
  1021. Clark, Richard A., Polypeptides and methods of use.
  1022. Deussen, Heinz-Josef; Olsen, Arne Agerlin; Fatum, Tine Muxoll; Roggen, Erwin Ludo, Polypeptides conjugated to copolymers of ethylene oxide and propylene oxide to reduce allergenicity.
  1023. Olsen Arne Agerlin,DKX ; Fatum Tine Muxoll,DKX ; Deussen Heinz Josef,DKX ; Roggen Erwin Ludo,DKX, Polypeptides conjugated with polymers.
  1024. Magruder Judy A. ; Eckenhoff James B. ; Cortese Richard ; Wright Jeremy C. ; Peery John R., Polyurethane-containing delivery systems.
  1025. Mirkin, Chad A.; Giljohann, David A.; Seferos, Dwight S.; Prigodich, Andrew E.; Patel, Pinal C., Polyvalent RNA-nanoparticle compositions.
  1026. Mirkin, Chad A.; Giljohann, David A.; Seferos, Dwight; Prigodich, Andrew E.; Patel, Pinal C., Polyvalent RNA-nanoparticle compositions.
  1027. Gerarda Havenith, Catharina Emanuele; Vink, Tom; Berkel, Patrick Van; Parren, Paul, Potency assays for antibody drug substance binding to an Fc receptor.
  1028. Nho, Kwang; Hyun, Changmin; Lee, Junghun; Pak, Youngkyoung, Preparation method of peg-maleimide derivatives.
  1029. Nitecki Danute E. (Berkeley CA) Katre Nandini (El Cerrito CA) Goodson Robert J. (Albany CA) Aldwin Lois (San Mateo CA), Preparation of a polymer/interleukin-2 conjugate.
  1030. Hazra, Partha; Shivarudraiah, Manjunath Hadavanahalli; Khedkar, Anand; Iyer, Harish; Dave, Nitesh; Krishnan, Gautam; Suryanarayan, Shrikumar, Preparation of insulin conjugates.
  1031. Zalipsky,Samuel, Preparation of macromolecular conjugates by four-component condensation reaction.
  1032. Meyer Damon L. ; Mallett Robert W., Pretargeting methods and compounds.
  1033. Ladner, Robert C.; Ley, Arthur C., Prevention and reduction of blood loss.
  1034. Ladner, Robert C.; Ley, Arthur C., Prevention and reduction of blood loss.
  1035. Ladner, Robert C.; Ley, Arthur C.; Hirani, Shirish; Williams, Anthony, Prevention and reduction of blood loss.
  1036. Ladner, Robert C.; Ley, Arthur C.; Hirani, Shirish; Williams, Anthony, Prevention and reduction of blood loss.
  1037. Ladner, Robert C.; Ley, Arthur C.; Hirani, Shirish; Williams, Anthony, Prevention and reduction of blood loss.
  1038. Ladner, Robert Charles; Ley, Arthur Charles; Hirani, Shirish; Williams, Anthony, Prevention and reduction of blood loss.
  1039. Ladner,Robert C.; Ley,Arthur C.; Hirani,Shirish; Williams,Anthony, Prevention and reduction of blood loss.
  1040. Ladner,Robert C.; Ley,Arthur C.; Hirani,Shirish; Williams,Anthony, Prevention and reduction of blood loss.
  1041. Sabbadini, Roger A., Prevention and treatment of pain using antibodies to sphingosine-1-phosphate.
  1042. Thorn, Karina; Toby, Garabet G.; Mezo, Adam R., Pro-coagulant compounds and methods of use thereof.
  1043. Cristina Delgado GB; Gillian Elizabeth Francis GB; Derek Fisher GB, Process for fractionating polyethylene glycol (PEG) -protein adducts and an adduct of PEG and granulocyt-macrophage colony stimulating factor.
  1044. Delgado Cristina,GBX ; Francis Gillian Elizabeth,GBX ; Fisher Derek,GBX, Process for fractionating polyethylene glycol (PEG)-protein adducts and an adduct of PEG and granulocyte-macrophage colo.
  1045. Bremner, Stacy; Evarts, Jerry; Sujino, Keiko; Tran, Duong; Vizitiu, Dragos, Process for preparing phosphatidylinositol 3-kinase inhibitors and intermediates thereof.
  1046. Faure,Marie Pierre; Ibea,Micheal, Process for the preparation of activated polyethylene glycols.
  1047. Faure,Marie Pierre; Shingel,Kirill, Process for the preparation of activated polyethylene glycols.
  1048. Faure, Marie-Pierre; Shingel, Kirill, Process for the preparation of activated polythylene glycols.
  1049. Dave, Nitesh; Hazra, Partha; Goel, Anuj; Roy, Nita; Khedkar, Anand; Iyer, Harish; Krishnan, Gautam; Manjunath, H. S.; Suryanarayan, Shrikumar; Manikam, Govindasamy; Sachdev, Goldy; Garg, Mayank, Process for the preparation of insulin conjugate IN-105.
  1050. DeFrees, Shawn; Bowe, Caryn, Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography.
  1051. Bremner, Stacy; Evarts, Jerry; Sujino, Keiko; Tran, Duong; Vizitiu, Dragos, Process methods for phosphatidylinositol 3-kinase inhibitors.
  1052. Bremner, Stacy; Evarts, Jerry; Sujino, Keiko; Tran, Duong; Vizitiu, Dragos, Process methods for phosphatidylinositol 3-kinase inhibitors.
  1053. Ehrich, Mathias; Nygren, Anders Olof Herman, Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses.
  1054. Ehrich, Mathias; Nygren, Anders Olof Herman; Jensen, Taylor Jacob, Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses.
  1055. Ehrich, Mathias; Mistro, Guy Del; Deciu, Cosmin; Chen, Yong Qing; McCullough, Ron Michael; Tim, Roger Chan, Processes and kits for identifying aneuploidy.
  1056. Radhakrishnan, Balasingam; Soltero, Richard; Ekwuribe, Nnochiri N., Proinsulin polypeptide-oligomer conjugates.
  1057. Weisgerber, David John; Rubingh, Donn Nelton; Correa, Paul Elliott, Protease conjugates having sterically protected clip sites.
  1058. Rubingh, Donn Nelton; Weisgerber, David John; Correa, Paul Elliott, Protease conjugates having sterically protected epitope regions.
  1059. Nielsen, Peter Kresten; Hubalek, Frantisek; Lautrup-Larsen, Inger; Ludvigsen, Svend; Ribel-Madsen, Ulla; Balschmidt, Per; Nørgaard, Per; Havelund, Svend, Protease resistant insulin analogues.
  1060. Madsen, Peter; Kjeldsen, Thomas B.; Hoeg-Jensen, Thomas; Jakobsen, Palle; Tagmose, Tina Moeller; Kodra, Janos Tibor, Protease stabilized acylated insulin analogues.
  1061. Madsen, Peter; Kjeldsen, Thomas Boerglum; Hoeg-Jensen, Thomas; Jakobsen, Palle; Tagmose, Tina Moeller; Glendorf, Tine; Kodra, Janos Tibor; Garibay, Patrick William; Petersen, Jacob Sten, Protease stabilized acylated insulin analogues.
  1062. Nielsen, Peter Kresten; Hubalek, Frantisek; Lautrup-Larsen, Inger; Balschmidt, Per; Ludvigsen, Svend; Kjeldsen, Thomas Børglum, Protease-stabilized insulin analogues.
  1063. David John Weisgerber ; Donn Nelton Rubingh ; Paul Elliott Correa, Proteases having modified amino acid sequences conjugated to addition moieties.
  1064. Dörwald, Florencio Zaragoza, Protein conjugates and methods for their preparation.
  1065. Suzuki Yosuke,JPX ; Sato Syuji,JPX, Protein or polypeptide, method for producing the same and intermediate compound therefor.
  1066. DeFrees, Shawn; Zopf, David; Bayer, Robert; Hakes, David; Chen, Xi, Protein remodeling methods and proteins/peptides produced by the methods.
  1067. Goto, Masaaki; Tsuda, Eisuke; Mochizuki, Shin'ichi; Yano, Kazuki; Kobayashi, Fumie; Shima, Nobuyuki; Yasuda, Hisataka; Nakagawa, Nobuaki; Morinaga, Tomonori; Ueda, Masatsugu; Higashio, Kanji, Proteins and methods for producing the proteins.
  1068. Goto,Masaaki; Tsuda,Eisuke; Mochizuki,Shin'ichi; Yano,Kazuki; Kobayashi,Fumie; Shima,Nobuyuki; Yasuda,Hisataka; Nakagawa,Nobuaki; Morinaga,Tomonori; Ueda,Masatsugu; Higashio,Kanji, Proteins and methods for producing the proteins.
  1069. Goto,Masaaki; Tsuda,Eisuke; Mochizuki,Shin'ichi; Yano,Kazuki; Kobayashi,Fumie; Shima,Nobuyuki; Yasuda,Hisataka; Nakagawa,Nobuaki; Morinaga,Tomonori; Ueda,Masatsugu; Higashio,Kanji, Proteins and methods for producing the proteins.
  1070. Patton, John S.; Kuo, Mei-Chang; Harris, J. Milton; Leach, Chester; Perkins, Kimberly; Bueche, Blaine, Pulmonary administration of chemically modified insulin.
  1071. Niven, Ralph; Pitt, Colin G, Pulmonary administration of granulocyte colony stimulating factor.
  1072. Fischer, Meir; Harosh, Eliyahu, Purification of proteins with cationic surfactant.
  1073. Nygren, Anders, Quantification of a minority nucleic acid species.
  1074. Nygren, Anders, Quantification of a minority nucleic acid species.
  1075. Nygren, Anders, Quantification of a minority nucleic acid species.
  1076. Fowler, Kerry W.; Huang, Danwen; Kesicki, Edward A.; Ooi, Hua Chee; Oliver, Amy; Ruan, Fuqiang; Treiberg, Jennifer, Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta.
  1077. Fowler, Kerry W.; Huang, Danwen; Kesicki, Edward A.; Ooi, Hua Chee; Oliver, Amy; Ruan, Fuqiang; Treiberg, Jennifer; Puri, Kamal Deep, Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta.
  1078. Fowler, Kerry W.; Huang, Danwen; Kesicki, Edward A.; Ooi, Hua Chee; Oliver, Amy; Ruan, Fuqiang; Treiberg, Jennifer; Puri, Kamal Deep, Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta.
  1079. Anderson, Dirk M, RANK ligand polypeptides.
  1080. Soliman, Tarik; Hales, Laura M.; Hall, Daniel B.; Sard, Howard P.; Hegde, Vishnumurthy, RNAi vitamin D conjugates.
  1081. Moore, Gregory L.; Desjarlais, John; Bernett, Matthew, Rapid clearance of antigen complexes using novel antibodies.
  1082. Zhao, Hong; Martinez, Anthony J., Reacting polyalkylene oxide with base, tertiary alkyl haloacetate, then acid to prepare polyalkylene oxide carboxylic acid.
  1083. Halenbeck, Robert F.; Kriegler, Michael; Tuttleman, Jan; Perez, Carl; Jewell, David A.; Koths, Kirston E., Recombinant PR-3 and assays employing the same.
  1084. Halenbeck, Robert F.; Kriegler, Michael; Perez, Carl; Jewell, David A.; Koths, Kirston E., Recombinant PR-3 and compositions thereof.
  1085. Yim, Kalvin; Danso, Steven; Hausknecht, Edward, Recombinant butyrylcholinesterases and truncates thereof.
  1086. Yim, Kalvin; Danso, Steven; Hausknecht, Edward, Recombinant butyrylcholinesterases and truncates thereof.
  1087. Wang, Haitao; Mao, Chungsheng; Li, Jizhi; Xu, Jing; Zhang, Rui; Wang, Ling; Du, Yong; Liu, Longbin, Recombinant human interferon-like proteins.
  1088. Wang, Haitao; Mao, Chunsheng; Li, Jizhi; Wang, Ling; Du, Yong; Liu, Longbin; Xu, Jing; Zhang, Rui, Recombinant human interferon-like proteins.
  1089. Wang, Haitao; Mao, Chunsheng; Li, Jizhi; Wang, Ling; Du, Yong; Liu, Longbin; Xu, Jing; Zhang, Rui, Recombinant human interferon-like proteins.
  1090. Wang, Haitao; Mao, Chunsheng; Li, Jizhi; Xu, Jing; Zhang, Rui; Wang, Ling; Du, Yong; Liu, Longbin, Recombinant human interferon-like proteins.
  1091. Wang, Haitao; Mao, Chunsheng; Li, Jizhi; Xu, Jing; Zhang, Rui; Wang, Ling; Du, Yong; Liu, Longbin, Recombinant human interferon-like proteins.
  1092. Wang, Haitao; Mao, Chunsheng; Li, Jizhi; Wang, Ling; Du, Yong; Liu, Longbin; Xu, Jing; Zhang, Rui, Recombinant human interferon-like proteins and method of treatment using them.
  1093. Fisher, Timothy C.; Armstrong, Jonathan K., Red blood cells covalently bound with polymers.
  1094. Fisher Timothy C. ; Armstrong Jonathan K., Red blood cells covalently bound with two different polyethylene glycol derivatives.
  1095. Wilmen, Andreas; Haupts, Ulrich; Freiberg, Christoph; Trautwein, Mark; Linden, Lars; Leineweber, Kirsten; Tinel, Hanna, Relaxin fusion polypeptides and uses thereof.
  1096. Samuel Zalipsky, Releasable linkage and compositions containing same.
  1097. Zalipsky, Samuel, Releasable linkage and compositions containing same.
  1098. Zalipsky, Samuel, Releasable linkage and compositions containing same.
  1099. Zalipsky, Samuel, Releasable linkage and compositions containing same.
  1100. Zalipsky, Samuel; Kiwan, Radwan, Releasable linkage and compositions containing same.
  1101. Zalipsky,Samuel, Releasable linkage and compositions containing same.
  1102. Zalipsky,Samuel; Kiwan,Radwan, Releasable linkage and compositions containing same.
  1103. Zhao, Hong; Greenwald, Richard B.; Adler, legal representative, Susan L., Releasable polymeric conjugates based on aliphatic biodegradable linkers.
  1104. Zhao, Hong; Greenwald, Richard B.; Pendri, Annapurna, Releasable polymeric conjugates based on aliphatic biodegradable linkers.
  1105. Zhao,Hong; Greenwald,Richard B., Releasable polymeric conjugates based on aliphatic biodegradable linkers.
  1106. Zhao,Hong; Greenwald,Richard B.; Pendri,Annapurna, Releasable polymeric conjugates based on aliphatic biodegradable linkers.
  1107. Zhao,Hong; Adler, legal representative,Susan; Greenwald,Richard B., Releasable polymeric conjugates based on biodegradable linkers.
  1108. DeFrees,Shawn; Zopf,David A.; Bayer,Robert J.; Hakes,David James; Bowe,Caryn; Chen,Xi, Remodeling and glycoconjugation of peptides.
  1109. DeFrees,Shawn; Zopf,David A.; Bowe,Caryn, Remodeling and glycoconjugation of peptides.
  1110. DeFrees,Shawn; Zopf,David A.; Bowe,Caryn, Remodeling and glycoconjugation of peptides.
  1111. DeFrees, Shawn, Remodeling and glycopegylation of fibroblast growth factor (FGF).
  1112. Rozema,David B.; Wakefield,Darren; Wolff,Jon A.; Ekena,Kirk; Hagstrom,James E., Reversible modification of amine-containing compounds.
  1113. Sebti, Said M.; Hamilton, Andrew D., Rock inhibitors and uses thereof.
  1114. French, Dorothy; Ashkenazi, Avi J.; Stephan, Jean-Philippe F.; Desnoyers, Luc, Screening method.
  1115. McManus, Samuel P.; Kozlowski, Antoni, Segmented degradable polymers and conjugates made therefrom.
  1116. McManus, Samuel P.; Kozlowski, Antoni, Segmented degradable polymers and conjugates made therefrom.
  1117. Zundel, Magali A.; Peschke, Bernd; Dörwald, Florencio Zaragoza; Fiil, Niels Peter; Johansen, Nils Langeland; Stennicke, Henning Ralf, Selectively conjugated peptides and methods of making the same.
  1118. Rubingh, Donn Nelton; Sikorski, Elizabeth Ellen; Correa, Paul Elliott, Serine protease variants having amino acid deletions and substitutions.
  1119. Rubingh, Donn Nelton; Sikorski, Elizabeth Ellen; Correa, Paul Elliott, Serine protease variants having amino acid substitutions.
  1120. Lapidot, Tsvee; Kalinkovich, Alexander; Fridkin, Matityahu, Short beta-defensin-derived peptides.
  1121. Lapidot, Tsvee; Kalinkovich, Alexander; Fridkin, Matityahu, Short beta-defensin-derived peptides.
  1122. DeFrees,Shawn; Zopf,David; Bayer,Robert; Bowe,Caryn; Hakes,David; Chen,Xi, Sialic acid nucleotide sugars.
  1123. Thompson, Peter Armstrong; Ledbetter, Jeffrey A.; Hayden-Ledbetter, Martha Susan; Grosmaire, Laura Sue; Bader, Robert; Brady, William, Single chain multivalent binding proteins with effector function.
  1124. Filpula David ; Wang Maoliang ; Shorr Robert ; Whitlow Marc ; Lee Lihsyng S., Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof.
  1125. Filpula, David; Wang, Maoliang; Shorr, Robert; Whitlow, Marc; Lee, Lihsyng S., Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof.
  1126. Filpula, David; Wang, Maoliang; Shorr, Robert; Whitlow, Marc; Lee, Lihsyng S., Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof.
  1127. Pettit, Dean K., Site protected protein modification.
  1128. Dean K. Pettit, Site specific protein modification.
  1129. Dean K. Pettit, Site specific protein modification.
  1130. Pettit,Dean K., Site specific protein modification.
  1131. Kim, Seung Su; Lim, Se Young; Jung, Sung Youb; Kwon, Se Chang, Site-specific GLP-2 conjugate using an immunoglobulin fragment.
  1132. Usera, Aimee; Robinson, Zachary; Cobb, Jennifer, Site-specific chemoenzymatic protein modifications.
  1133. Hinds, Kenneth; Lewis, Danny; Schmidt, Paul; Campbell, Kathleen M., Site-specific insulin-polymer conjugates.
  1134. Tonon, Giancarlo; Orsini, Gaetano; Sergi, Mauro; Schrepfer, Rodolfo; Esposito, Pierandrea, Site-specific monoconjugated insulinotropic GLP-1 peptides.
  1135. Katre Nandini (El Cerrito CA) Knauf Michael J. (Oakland CA), Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation.
  1136. Koths Kirston ; Taylor Eric, Soluble extracellular domain of human M-CSF receptor.
  1137. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  1138. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  1139. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  1140. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  1141. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  1142. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  1143. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  1144. Bookbinder, Louis; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  1145. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof.
  1146. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof.
  1147. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof.
  1148. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof.
  1149. Bookbinder, Louis H.; Kundu, Anirbau; Frost, Gregory I., Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof.
  1150. Bookbinder, Louis; Kundu, Anirban; Frost, Gregory I., Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof.
  1151. Harris, J. Milton, Soluble, degradable poly (ethylene glycol) derivatives for controllable release of bound molecules into solution.
  1152. Harris, J. Milton, Soluble, degradable poly (ethylene glycol) derivatives for controllable release of bound molecules into solution.
  1153. Harris J. Milton, Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution.
  1154. Harris, J. Milton, Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution.
  1155. Harris, J. Milton, Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution.
  1156. Harris, J. Milton, Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution.
  1157. Holmes, Christopher P.; Tumelty, David; Yin, Qun, Spacer moiety for poly(ethylene glycol) modified peptide based compounds.
  1158. Daley Michael Joseph ; Buckwalter Brian Lee ; Cady Susan Mancini ; Shieh Hong-Ming ; Bohlen Peter ; Seddon Andrew P., Stabilization of fibroblast growth factors by modification of cysteine residues.
  1159. Hamilton ; Jr. Edwin J. (Terre Haute IN) Burleigh Bruce D. (Mundelein IL), Stabilization of growth hormones.
  1160. Daley Michael Joseph ; Buckwalter Brian Lee ; Cady Susan Mancini ; Shieh Hong-Ming ; Bohlen Peter ; Seddon Andrew P., Stabilization of somatotropins and other proteins by modification of cysteine residues.
  1161. Schnieders, Julia; Usener, Dirk; Ruggeberg, Sabrina; Youssef, Ahmed; Kirsch, Martina; Hagendorf, Annika, Stable IgG4 based binding agent formulations.
  1162. Teschner, Wolfgang; Svatos, Sonja; Bruckschwaiger, Leopold; Weber, Alfred; Schwarz, Hans-Peter; Lei, Laura, Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof.
  1163. Yang, Tzung-Horng; Vaughn, Daniel Edward; Labarre, Michael James; Caster, Christopher L.; Nicol, Francois; Kim, Donghyun, Stable formulations of a hyaluronan-degrading enzyme.
  1164. Park, Myung Ok, Stoichiometric conjugates of biocompatible polymers at the unpaired cysteine residue of the wild-type G-CSF.
  1165. Pennica,Diane; Smith,Victoria; Wood,William I., Stra6 polypeptides.
  1166. Ekwuribe,Nnochiri N.; Price,Christopher H.; Ansari,Aslam M.; Odenbaugh,Amy L., Substantially monodispersed mixtures of polymers having polyethylene glycol moieties.
  1167. Lee Seoju ; McNemar Charles, Substantially pure histidine-linked protein polymer conjugates.
  1168. Ashkenazi, Avi J.; Kelley, Robert F.; O'Connell, Mark P.; Pitti, Robert M.; Schwall, Ralph A., Substitutional variants of APO-2 ligand.
  1169. Rubingh, Donn Nelton; Sikorski, Elizabeth Ellen, Subtilisin protease variants having amino acid deletions and substitutions in defined epitope regions.
  1170. Sikorski, Elizabeth Ellen; Rubingh, Donn Nelton, Subtilisin protease variants having amino acid substitutions in defined epitope regions.
  1171. Frost, Gregory I.; Bilinsky, Igor; Vaughn, Daniel; Sugarman, Barry, Super fast-acting insulin compositions.
  1172. Frost, Gregory I.; Bilinsky, Igor; Vaughn, Daniel; Sugarman, Barry, Super fast-acting insulin compositions.
  1173. Craft, Charles E., Suppression of cellular transformation and dysplasia by topical application of lefty.
  1174. Liu Feng ; Kim Sung Wan ; Baudys Miroslav, Synthesis of insulin derivatives.
  1175. Cummings,Richard D.; McEver,Rodger P., Synthetic glycosulfopeptides and methods of synthesis thereof.
  1176. Rhee, Woonza M.; DeLustro, Frank A.; Berg, Richard A., Synthetic implant with nonimmunogenicity coating.
  1177. Cassingham, Charles Vaughn; Mezger, William Jerome, Systems, methods, and compositions for prevention of tissue adhesion.
  1178. Cassingham, Charles Vaughn; Mezger, William Jerome, Systems, methods, and compositions for prevention of tissue adhesion.
  1179. Peled, Amnon; Begin, Michal; Beider, Katia; Abraham, Michal, T-140 peptide analogs having CXCR4 super-agonist activity for cancer therapy.
  1180. Peled, Amnon; Begin, Michal; Beider, Katia; Abraham, Michal, T-140 peptide analogs having CXCR4 super-agonist activity for immunomodulation.
  1181. Voytas, Daniel F.; Bogdanove, Adam J.; Zhang, Feng, TAL effector-mediated DNA modification.
  1182. Voytas, Daniel F.; Bogdanove, Adam J.; Zhang, Feng, TAL effector-mediated DNA modification.
  1183. Voytas, Daniel F.; Bogdanove, Adam J.; Zhang, Feng, TAL effector-mediated DNA modification.
  1184. Voytas, Daniel F.; Bogdanove, Adam J.; Zhang, Feng, TAL effector-mediated DNA modification.
  1185. Voytas, Daniel F.; Bogdanove, Adam; Zhang, Feng; Christian, Michelle; Cermak, Tomas; Schmidt, Clarice Lauer; Doyle, Erin; Wang, Li, TAL effector-mediated DNA modification.
  1186. Dockal, Michael; Ehrlich, Hartmut; Scheiflinger, Friedrich; Reimer, Ulf; Reineke, Ulrich; Polakowski, Thomas; Schneider, Eberhard, TFPI inhibitors and methods of use.
  1187. Dockal, Michael; Ehrlich, Hartmut; Scheiflinger, Friedrich; Reimer, Ulf; Reineke, Ulrich; Polakowski, Thomas; Schneider, Eberhard, TFPI inhibitors and methods of use.
  1188. Dockal, Michael; Hartmann, Rudolf; Fries, Markus; Scheiflinger, Friedrich; Ehrlich, Hartmut; Reineke, Ulrich; Osterkamp, Frank; Polakowski, Thomas, TFPI inhibitors and methods of use.
  1189. Dockal, Michael; Hartmann, Rudolf; Fries, Markus; Scheiflinger, Friedrich; Ehrlich, Hartmut; Reineke, Ulrich; Osterkamp, Frank; Polakowski, Thomas, TFPI inhibitors and methods of use.
  1190. Dockal, Michael; Hartmann, Rudolf; Fries, Markus; Scheiflinger, Friedrich; Ehrlich, Hartmut; Reineke, Ulrich; Osterkamp, Frank; Polakowski, Thomas, TFPI inhibitors and methods of use.
  1191. Dockal, Michael; Hartmann, Rudolf; Fries, Markus; Scheiflinger, Friedrich; Ehrlich, Hartmut; Reineke, Ulrich; Osterkamp, Frank; Polakowski, Thomas, TFPI inhibitors and methods of use.
  1192. Dockal, Michael; Hartmann, Rudolf; Scheiflinger, Friedrich; Osterkamp, Frank; Polakowski, Thomas; Reineke, Ulrich, TFPI inhibitors and methods of use.
  1193. Dockal, Michael; Hartmann, Rudolf; Scheiflinger, Friedrich; Osterkamp, Frank; Polakowski, Thomas; Reineke, Ulrich, TFPI inhibitors and methods of use.
  1194. Voytas, Daniel F.; Bogdanove, Adam J.; Zhang, Feng, Tal effector-mediated DNA modification.
  1195. Sigurdsson, Einar M., Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy.
  1196. Mirkin, Chad A.; Giljohann, David A.; Daniel, Weston L.; Cutler, Joshua I.; Zhang, Ke; Zheng, Dan, Templated nanoconjugates.
  1197. Mirkin, Chad A.; Giljohann, David A.; Daniel, Weston L.; Cutler, Joshua I.; Zhang, Ke; Zheng, Dan, Templated nanoconjugates.
  1198. Anthony J. Martinez ; Annapurna Pendri ; Richard B. Greenwald ; Yun H. Choe, Terminally-branched polymeric linkers and polymeric conjugates containing the same.
  1199. Martinez Anthony J. ; Pendri Annapurna ; Greenwald Richard B. ; Choe Yun H., Terminally-branched polymeric linkers and polymeric conjugates containing the same.
  1200. Martinez, Anthony J.; Pendri, Annapurna; Greenwald, Richard B.; Choe, Yun H., Terminally-branched polymeric linkers and polymeric conjugates containing the same.
  1201. Greenwald, Richard B.; Zhao, Hong, Tetrapartate prodrugs.
  1202. Dunn Joseph T. (Holliston MA), Therapeutic enzyme-antibody complexes.
  1203. Walker, Kenneth W.; Kinstler, Olaf B.; Sitney, Karen C., Therapeutic peptides.
  1204. Morris, David W.; Malandro, Marc S., Therapeutic targets in cancer.
  1205. Morris, David W.; Malandro, Marc S., Therapeutic targets in cancer.
  1206. Soliman, Tarik; Hales, Laura M.; Hall, Daniel B.; So, Christopher; Sard, Howard P.; Hegde, Vishnumurthy, Therapeutic vitamin D conjugates.
  1207. Gallatin, W. Michael; Ulrich, Roger G.; Giese, Neill A., Therapies for hematologic malignancies.
  1208. Gallatin, W. Michael; Ulrich, Roger G.; Giese, Neill A.; Lannutti, Brian; Miller, Langdon; Jahn, Thomas M., Therapies for hematologic malignancies.
  1209. Gallatin, W. Michael; Ulrich, Roger G.; Giese, Neill A.; Lannutti, Brian; Miller, Langdon; Jahn, Thomas M., Therapies for hematologic malignancies.
  1210. Jeong,Byeongmoon; Gutowska,Anna, Thermogelling oligopeptide polymers.
  1211. Peters, Lars-Erik; Fang, Nan, Thermus egertssonii DNA polymerases.
  1212. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  1213. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  1214. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  1215. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  1216. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  1217. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  1218. Min, Hosung; Walker, Kenneth W.; Gegg, Colin V.; Galimi, Francesco; Sun, Jeonghoon; Tsai, Mei-Mei, Thrombopoietic compounds.
  1219. Min, Hosung; Walker, Kenneth W.; Gegg, Jr., Colin V.; Galimi, Francesco; Sun, Jeonghoon; Tsai, Mei-Mei, Thrombopoietic compounds.
  1220. Rudolph,Alfred R.; Tuthill,Cynthia W., Thymosin alpha 1 peptide/polymer conjugates.
  1221. Silbiger, Scott M.; Koski, Raymond A., Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods.
  1222. Silbiger, Scott M.; Koski, Raymond A., Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods.
  1223. Silbiger, Scott M.; Koski, Raymond A., Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods.
  1224. Silbiger,Scott M.; Koski,Raymond A., Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods.
  1225. Silbiger,Scott M.; Koski,Raymond A., Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods.
  1226. Fortune, David Harry; Kettlewell, Graeme; Mandley, David John; Thompson, Ian; Cook, Diane, Tissue-adhesive formulations.
  1227. Kettlewell, Graeme; Mandley, David John; Fortune, David Harry; Thompson, Ian; Morris, Diane, Tissue-adhesive materials.
  1228. Kettlewell, Graeme; Mandley, David; Fortune, David; Thompson, Ian; Morris, Diane, Tissue-adhesive materials.
  1229. Walker, Kenneth William; Xiong, Fei, Transthyretin variants.
  1230. Adams, Camellia W.; Ashkenazi, Avi J.; Chuntharapai, Anan; Kim, Kyung Jin, Treatment of cancer using anti-Apo-2 antibodies.
  1231. Mirza, Amer M.; Akhurst, Rosemary J.; Li, Ou, Treatment of cancer using anti-TGF-BETA and PD-1 antibodies.
  1232. Lehmann,Paul; Roeddiger,Ralf; Walter Matsui,Ruth, Treatment of disturbances of iron distribution.
  1233. Lehmann,Paul; Roeddiger,Ralf; Walter Matsui,Ruth, Treatment of disturbances of iron distribution.
  1234. Ulrich, Roger G., Treatment of liver disorders with PI3K inhibitors.
  1235. Sternlicht, Andrew, Treatment of mucositis with kallikrein inhibitors.
  1236. Creasey, Abla, Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (TFPI).
  1237. Wei, Guangwen; Guo, Rongbing; Zhang, Renhuai, Treatment of tumors with recombinant interferon alpha.
  1238. Wei, Guangwen; Guo, Rongbing; Zhang, Renhuai, Treatment of viral diseases with recombinant interferon α.
  1239. Mottl, Harald, Treatment with anti-alpha2 integrin antibodies.
  1240. Smith, Alan E.; O'Riordan, Catherine R.; Francis, Gillian E.; Parkes, Vincent; Delgado, Christina, Tresyl-monomethoxypolyethylene glycol-modified viruses having viral infectivity.
  1241. Greenwald Richard B. ; Choe Yun H., Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents.
  1242. Greenwald Richard B. ; Choe Yun H. ; Pendri Annapurna, Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents.
  1243. Greenwald, Richard B.; Zhao, Hong, Trimethyl lock based tetrapartate prodrugs.
  1244. Fisher,Eric F.; Edwards, III,Carl K.; Kieft,Gary L., Truncated soluble tumor necrosis factor type-I and type-II receptors.
  1245. Brewer Michael T. ; Hale Karin K. ; King Michael W. ; Kohno Tadahiko ; Squires Charles ; Thompson Robert C. ; Vanderslice Rebecca W. ; Vannice James, Tumor necrosis factor (TNF) inhibitor and method for obtaining the same.
  1246. Banner David (Basle CHX) Lesslauer Werner (Riehen CHX) Lotscher Hansruedi (Mohlin CHX) Stuber Dietrich (Grenzach-Wyhlen DEX), Tumor necrosis factor muteins.
  1247. Ying-Fei Wei ; Jian Ni ; Reiner L. Gentz ; Steven M. Ruben, Tumor necrosis factor receptor 5.
  1248. Yu, Guo Liang; Ni, Jian; Rosen, Craig A.; Zhang, Jun, Tumor necrosis factor-gamma.
  1249. Yu, Guo-Liang; Ni, Jian; Rosen, Craig A.; Zhang, Jun, Tumor necrosis factor-gamma.
  1250. Yu, Guo-Liang; Ni, Jian; Rosen, Craig A.; Zhang, Jun, Tumor necrosis factor-gamma.
  1251. Bossard, Mary J.; Bentley, Michael D.; Zhang, Ping, Unit dosage forms of pharmaceutical compositions comprising a polymer-factor VIII polypeptide conjugate.
  1252. Hershfield,Michael; Kelly,Susan J., Urate oxidase.
  1253. Lucas, John; Briggs, Kristen, Use of adipsin/complement factor D in the treatment of metabolic related disorders.
  1254. Sabbadini, Roger A.; Garland, William A., Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents.
  1255. Shami Ezekiel Y. (Ontario CAX) Rothstein Aser (Ontario CAX) Ramjeesingh Mohabir (Ontario CAX), Use of antibody/antigen interactions to protect biologically active proteins and peptides.
  1256. Bennett,D. Clark; Cauchon,Elizabeth; Fink,Dominique; Grouix,Brigette; Hsia,Ariane; Danagher,Pamela; Zimmermann,Joseph F., Use of heparinases to decrease inflammatory response.
  1257. Rosendahl, Mary S.; Mantripragada, Sankaram B.; Gomez, Eliana B., Use of hydrophobic organic acids to increase hydrophobicity of proteins and protein conjugates.
  1258. Arnould, Sylvain; Bruneau, Sylvia; Cabaniols, Jean-Pierre; Chames, Patrick; Choulika, Andre; Duchateau, Philippe; Epinat, Jean-Charles; Gouble, Agnes; Lacroix, Emmanuel; Paques, Frederic; Perez-Michaut, Christophe; Smith, Julianne; Sourdive, David, Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof.
  1259. Arnould, Sylvain; Chames, Patrick; Duchateau, Philippe; Epinat, Jean-Charles; Lacroix, Emmanuel; Paques, Frederic, Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof.
  1260. Arnould, Sylvain; Chames, Patrick; Duchateau, Phillippe; Epinat, Jean-Charles; Lacroix, Emmanuel; Paques, Frederic, Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof.
  1261. Arnould, Sylvain; Chames, Patrick; Duchateau, Phillippe; Epinat, Jean-Charles; Lacroix, Emmanuel; Paques, Frederic, Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof.
  1262. Soane, David S.; Suich, Daniel J., Use of oligomers and polymers for drug solubilization, stabilization, and delivery.
  1263. Soane,David S.; Suich,Daniel J., Use of oligomers and polymers for drug solubilization, stabilization, and delivery.
  1264. Ellis Edward James ; Jahngen Edwin Georg Emil ; Meuse Arthur John, Use of water soluble enzyme-polymer conjugates for cleaning contact lenses.
  1265. Belouski, Edward John; Ellison, Murielle Marie; Hamburger, Agnes Eva; Hecht, Randy Ira; Li, Yue-Sheng; Michaels, Mark Leo; Sun, Jeonghoon; Xu, Jing, Uses of FGF21 polypeptides comprising two or more mutations.
  1266. Chen, Tingchao; Zhao, Yi; Anderson, W. French, Uses of IL-12 in hematopoiesis.
  1267. Chen, Tingchao; Zhao, Yi; Anderson, W. French, Uses of IL-12 in hematopoiesis.
  1268. Chen, Tingchao; Zhao, Yi; Anderson, W. French, Uses of IL-12 in hematopoiesis.
  1269. Matthews William ; Austin Timothy W., Uses of Wnt polypeptides.
  1270. Cohen, Ofer; Kronman, Chanoch; Chitlaru, Theodor; Velan, Baruch; Shafferman, Avigdor, Uses of chemically-modified cholinesterases for detoxification of organophosporus compounds.
  1271. Kirsebom, Leif; Dasgupta, Santanu; Larsson, Pontus; Ghosh, Jaydip, Vaccine for the treatment of Mycobacterium related disorders.
  1272. Hartman, Jacob; Mendelovitz, Simona, Variant form of urate oxidase and use thereof.
  1273. Hartman, Jacob; Mendelovitz, Simona, Variant form of urate oxidase and use thereof.
  1274. Hartman, Jacob; Mendelovitz, Simona, Variant form of urate oxidase and use thereof.
  1275. Hartman, Jacob; Mendelovitz, Simona, Variant form of urate oxidase and use thereof.
  1276. Hartman, Jacob; Mendelovitz, Simona, Variant form of urate oxidase and use thereof.
  1277. Hartman, Jacob; Mendelovitz, Simona, Variant forms of urate oxidase and use thereof.
  1278. Hartman, Jacob; Mendelovitz, Simona, Variant forms of urate oxidase and use thereof.
  1279. Hartman, Jacob; Mendelovitz, Simona, Variant forms of urate oxidase and use thereof.
  1280. Hartman, Jacob; Mendelovitz, Simona, Variant forms of urate oxidase and use thereof.
  1281. Hartman, Jacob; Mendelovitz, Simona, Variant forms of urate oxidase and use thereof.
  1282. Hartman, Jacob; Mendelovitz, Simona, Variant forms of urate oxidase and use thereof.
  1283. Hartman, Jacob; Mendelovitz, Simona, Variant forms of urate oxidase and use thereof.
  1284. Thomason, Arlen; Liu, Benxian, Vectors and recombinant host cells comprising nucleic acid molecules encoding Fibroblast Growth Factor-like polypeptides.
  1285. Soliman, Tarik; Hales, Laura M.; Sard, Howard P.; Amere, Mukkanti, Vitamin D-ghrelin conjugates.
  1286. Bossard, Mary J.; Stephenson, Gayle; Fang, Zhihao; Zappe, Harold; Mitchell, Stacy; Zhang, Ping; Scheiflinger, Friedrich; Turecek, Peter; Siekmann, Juergen; Varadi, Katalin; Gritsch, Herbert, Von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkage.
  1287. Bossard, Mary J.; Stephenson, Gayle; Fang, Zhihao; Zappe, Harold; Mitchell, Stacy; Zhang, Ping; Scheiflinger, Friedrich; Turecek, Peter; Siekmann, Juergen; Varadi, Katalin; Gritsch, Herbert, Von willebrand factor- and factor VIII-polymer conjugates having a releasable linkage.
  1288. Greenwald Richard B. ; Martinez Anthony J., Water-soluble non-antigenic polymer linkable to biologically active material.
  1289. Miranda, Leslie Philip; Kent, Stephen B. H., Water-soluble thioester and selenoester compounds and methods for making and using the same.
  1290. Wild Hanno,DEX ; Hanko Rudolf,DEX ; Dorschug Michael,DEX ; Horlein Hans-Dietrich,DEX ; Beunink Jurgen,DEX ; Apeler Heiner,DEX ; Wehlmann Hermann,DEX ; Sebald Walter,DEX, hIL-4 mutant proteins used as antagonists or partial agonists of human interleukin 4.
  1291. Bossard, Mary J.; Stephenson, Gayle; Fang, Zhihao; Zappe, Harold; Mitchell, Stacy; Zhang, Ping; Scheiflinger, Friedrich; Turecek, Peter; Siekmann, Juergen; Varadi, Katalin; Gritsch, Herbert, von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkage.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로